CHEWY, INC., 10-K filed on 3/20/2024
Annual Report
v3.24.1
Cover Page - USD ($)
$ in Billions
 12 Months Ended
Jan. 28, 2024
Mar. 13, 2024
Jul. 28, 2023
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 28, 2024    
Current Fiscal Year End Date --01-28    
Document Transition Report false    
Entity File Number 001-38936    
Entity Registrant Name CHEWY, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 90-1020167    
Entity Address, Address Line One 7700 West Sunrise Boulevard    
Entity Address, City or Town Plantation    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33322    
City Area Code 786    
Local Phone Number 320-7111    
Title of 12(b) Security Class A Common Stock, par value $0.01 per share    
Trading Symbol CHWY    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 3.9
Documents Incorporated by Reference
Portions of the registrant’s Definitive Proxy Statement relating to the 2024 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The registrant's Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended January 28, 2024.
    
Entity Central Index Key 0001766502    
Amendment Flag false    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   136,052,148  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   298,863,356  
v3.24.1
Audit Information
 12 Months Ended
Jan. 28, 2024
Audit Information [Abstract]  
Auditor Firm ID 34
Auditor Name Deloitte & Touche LLP
Auditor Location Miami, Florida
v3.24.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Current assets:    
Cash and cash equivalents $ 602,232 $ 331,641
Marketable securities 531,785 346,944
Accounts receivable 154,043 126,969
Inventories 719,273 678,005
Prepaid expenses and other current assets 97,015 41,221
Total current assets 2,104,348 1,524,780
Property and equipment, net 521,298 478,885
Operating lease right-of-use assets 474,617 423,518
Goodwill 39,442 39,442
Other non-current assets 47,146 53,193
Total assets 3,186,851 2,519,818
Current liabilities:    
Trade accounts payable 1,104,940 1,033,184
Accrued expenses and other current liabilities 1,005,937 794,534
Total current liabilities 2,110,877 1,827,718
Operating lease liabilities 527,795 471,821
Other long-term liabilities 37,935 60,011
Total liabilities 2,676,607 2,359,550
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.01 par value per share, 5,000,000 shares authorized, no shares issued and outstanding as of January 28, 2024 and January 29, 2023 0 0
Additional paid-in capital 2,481,984 2,171,247
Accumulated deficit (1,975,652) (2,015,232)
Accumulated other comprehensive loss (406) 0
Total stockholders’ equity 510,244 160,268
Total liabilities and stockholders’ equity 3,186,851 2,519,818
Class A Common Stock    
Stockholders’ equity:    
Common stock 1,329 1,141
Class B Common Stock    
Stockholders’ equity:    
Common stock $ 2,989 $ 3,112
v3.24.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jan. 28, 2024
Jan. 29, 2023
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 5,000,000 5,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 1,500,000,000 1,500,000,000
Common stock, issued (in shares) 132,913,046 114,160,531
Common stock, outstanding (in shares) 132,913,046 114,160,531
Class B common stock    
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 395,000,000 395,000,000
Common stock, issued (in shares)   311,188,356
Common stock, outstanding (in shares) 298,863,356 311,188,356
v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Income Statement [Abstract]      
Net sales $ 11,147,720 $ 10,119,000 $ 8,967,407
Cost of goods sold 7,986,202 7,284,505 6,581,936
Gross profit 3,161,518 2,834,495 2,385,471
Operating expenses:      
Selling, general and administrative 2,442,683 2,128,688 1,840,135
Advertising and marketing 742,460 649,386 618,902
Total operating expenses 3,185,143 2,778,074 2,459,037
(Loss) income from operations (23,625) 56,421 (73,566)
Interest income (expense), net 58,501 9,290 (1,641)
Other income (expense), net 13,354 (13,166) 0
Income (loss) before income tax provision 48,230 52,545 (75,207)
Income tax provision 8,650 2,646 0
Net income (loss) 39,580 49,899 (75,207)
Other comprehensive income (loss)      
Net income (loss) 39,580 49,899 (75,207)
Foreign currency translation adjustments (406) 0 0
Comprehensive income (loss) $ 39,174 $ 49,899 $ (75,207)
Earnings (loss) per share attributable to common Class A and Class B stockholders:      
Basic (in dollars per share) $ 0.09 $ 0.12 $ (0.18)
Diluted (in dollars per share) $ 0.09 $ 0.12 $ (0.18)
Weighted-average common shares used in computing earnings (loss) per share:      
Basic (in shares) 429,457 422,331 417,218
Diluted (in shares) 432,040 427,770 417,218
v3.24.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jan. 31, 2021   415,046      
Balance at beginning of period at Jan. 31, 2021 $ (54,970) $ 4,150 $ 1,930,804 $ (1,989,924) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 77,772   77,772    
Vesting of share-based compensation awards (in shares)   4,873      
Vesting of share-based compensation awards 0 $ 49 (49)    
Distribution to parent (in shares)   187      
Distribution to parent 0 $ 2 (2)    
Tax sharing agreement with related parties 12,785   12,785    
Net income (loss) (75,207)     (75,207)  
Balance at end of period (in shares) at Jan. 30, 2022   420,106      
Balance at end of period at Jan. 30, 2022 (39,620) $ 4,201 2,021,310 (2,065,131) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 158,122   158,122    
Vesting of share-based compensation awards (in shares)   5,109      
Vesting of share-based compensation awards 0 $ 51 (51)    
Tax withholdings for share-based compensation awards (in shares)   (53)      
Tax withholdings for share-based compensation awards (2,475) $ (1) (2,474)    
Distribution to parent (in shares)   187      
Distribution to parent 0 $ 2 (2)    
Tax sharing agreement with related parties (5,658)   (5,658)    
Net income (loss) 49,899     49,899  
Balance at end of period (in shares) at Jan. 29, 2023   425,349      
Balance at end of period at Jan. 29, 2023 160,268 $ 4,253 2,171,247 (2,015,232) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 239,106   239,106    
Vesting of share-based compensation awards (in shares)   6,334      
Vesting of share-based compensation awards 0 $ 64 (64)    
Tax withholdings for share-based compensation awards (in shares)   0      
Tax withholdings for share-based compensation awards (5) $ 0 (5)    
Distribution to parent (in shares)   93      
Distribution to parent 0 $ 1 (1)    
Tax sharing agreement with related parties (4,999)   (4,999)    
Noncash settlement with related parties 54,734   54,734    
Capital contribution from parent reorganization transaction 21,966   21,966    
Net income (loss) 39,580     39,580  
Other comprehensive loss (406)       (406)
Balance at end of period (in shares) at Jan. 28, 2024   431,776      
Balance at end of period at Jan. 28, 2024 $ 510,244 $ 4,318 $ 2,481,984 $ (1,975,652) $ (406)
v3.24.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Cash flows from operating activities      
Net income (loss) $ 39,580 $ 49,899 $ (75,207)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 109,693 83,440 55,319
Share-based compensation expense 239,107 158,122 77,772
Non-cash lease expense 37,818 39,389 32,996
Change in fair value of equity warrants and investments (13,069) 13,340 0
Unrealized foreign currency gains, net (391) 0 0
Other 3,914 1,072 595
Net change in operating assets and liabilities:      
Accounts receivable (27,072) (2,573) (20,858)
Inventories (41,259) (115,261) (41,745)
Prepaid expenses and other current assets (50,099) (10,964) (7,357)
Other non-current assets (29,942) 1,114 (4,960)
Trade accounts payable 71,762 147,465 84,058
Accrued expenses and other current liabilities 152,329 7,932 128,706
Operating lease liabilities (27,179) (21,632) (19,864)
Other long-term liabilities 21,019 (1,566) (17,712)
Net cash provided by operating activities 486,211 349,777 191,743
Cash flows from investing activities      
Capital expenditures (143,282) (230,310) (183,186)
Cash paid for acquisition of business, net of cash acquired (367) (40,033) 0
Purchases of marketable securities (3,221,714) (543,761) 0
Proceeds from maturities of marketable securities 3,078,000 200,000 0
Acquisition of assets 0 0 (10,086)
Other 0 (1,400) 0
Net cash used in investing activities (287,363) (615,504) (193,272)
Cash flows from financing activities      
Proceeds from parent reorganization transaction, net of cash paid for income taxes 60,601 0 0
Capital contribution from parent reorganization transaction 21,966 0 0
(Payments for) proceeds from tax sharing agreement with related parties (10,279) (2,828) 43,714
Principal repayments of finance lease obligations (510) (681) (869)
Payment of debt modification costs (175) (750) (1,584)
Payments for tax withholdings related to vesting of share-based compensation awards (5) (2,475) 0
Net cash provided by (used in) financing activities 71,598 (6,734) 41,261
Effect of exchange rate changes on cash and cash equivalents 145 0 0
Net increase (decrease) in cash and cash equivalents 270,591 (272,461) 39,732
Cash and cash equivalents, as of beginning of period 331,641 604,102 564,370
Cash and cash equivalents, as of end of period 602,232 331,641 604,102
Supplemental disclosure of cash flow information      
Cash paid for interest 2,872 2,058 2,053
Cash paid for income taxes $ 1,799,758 $ 0 $ 0
v3.24.1
Description of Business
 12 Months Ended
Jan. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business Description of Business
Chewy, Inc. and its wholly-owned subsidiaries (collectively “Chewy” or the “Company”) is a pure play e-commerce business geared toward pet products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. Chewy serves its customers through its retail websites, and its mobile applications and focuses on delivering exceptional customer service, competitive prices, outstanding convenience (including Chewy’s Autoship subscription program, fast shipping, and hassle-free returns), and a large selection of high-quality pet food, treats and supplies, and pet healthcare products.

The Company is controlled by a consortium including private investment funds advised by BC Partners Advisors LP (“BC Partners”) and its affiliates, La Caisse de dépôt et placement du Québec, affiliates of GIC Special Investments Pte Ltd, affiliates of StepStone Group LP and funds advised by Longview Asset Management, LLC (collectively, the “Sponsors”). The Company was controlled by PetSmart LLC (“PetSmart”), a wholly-owned subsidiary of the Sponsors, through February 11, 2021.

On October 30, 2023 (the “Closing Date”), the Company entered into certain transactions (the “Transactions”) with affiliates of BC Partners pursuant to an Agreement and Plan of Merger (the “Merger Agreement”). The Transactions resulted in such affiliates restructuring their ownership interests in the Company and Chewy Pharmacy KY, LLC (“Chewy Pharmacy KY”) becoming an indirect wholly-owned subsidiary of the Company.

Contemporaneously with the execution and delivery of the Merger Agreement, the Company and the BC Partners-affiliated stockholders named therein (the “BCP Stockholder Parties”) entered into an Amended and Restated Investor Rights Agreement (the “A&R Investor Rights Agreement”), which amended and restated in its entirety that certain Investor Rights Agreement, dated as of June 13, 2019, by and among the Company and the stockholders identified therein. The A&R Investor Rights Agreement contains changes to the governing arrangements between the BCP Stockholder Parties and the Company, including (i) the gradual elimination of the Company’s dual class share structure through the conversion of the Company’s Class B common stock (ten votes per share) into Class A common stock (one vote per share), (ii) certain revisions to the BCP Stockholder Parties director nomination rights which will accelerate the step down of their nomination rights as the economic ownership of the BCP Stockholder Parties decreases following the date that such stockholders no longer hold an aggregate of over 50% of the outstanding Class A and Class B common stock of the Company, (iii) the approval of a disinterested and independent committee of the Company’s board of directors for certain change of control transactions, (iv) certain standstill commitments, and (v) additional transfer restrictions.

On the Closing Date, affiliates of BC Partners transferred $1.9 billion to the Company to be used to fund: (i) tax obligations of its affiliates that were inherited by the Company as a result of the Transactions and (ii) expenses incurred by the Company in connection with the Transactions. The Merger Agreement requires affiliates of BC Partners to indemnify the Company for certain tax liabilities and includes customary indemnifications related to the Transactions. For additional information, see Note 12 – Income Taxes.
v3.24.1
Basis of Presentation and Significant Accounting Policies
 12 Months Ended
Jan. 28, 2024
Accounting Policies [Abstract]  
Basis of Presentation and Significant Accounting Policies Basis of Presentation and Significant Accounting Policies
Basis of Presentation

The Company’s accompanying consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) as set forth in the Financial Accounting Standards Board’s (“FASB”) accounting standards codification (“ASC”).

In connection with the Transactions described in Note 1 – Description of Business, the Company has provided restated consolidated financial statements and related notes for the historical comparative periods in this 10-K Report reflecting the operations of Chewy Pharmacy KY as part of the Company’s consolidated financial statements. This restatement was accounted for as a common control transaction, with Chewy Pharmacy KY’s net assets transferred at the previous parent company’s historical basis.
Fiscal Year

The Company has a 52- or 53-week fiscal year ending each year on the Sunday that is closest to January 31 of that year. The Company’s 2023 fiscal year ended January 28, 2024 and included 52 weeks (“Fiscal Year 2023”). The Company’s 2022 fiscal year ended January 29, 2023 and included 52 weeks (“Fiscal Year 2022”). The Company’s 2021 fiscal year ended January 30, 2022 and included 52 weeks (“Fiscal Year 2021”).

Principles of Consolidation

The consolidated financial statements and related notes include the accounts of Chewy, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

GAAP requires management to make certain estimates, judgments, and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates these estimates and judgments. Actual results could differ from those estimates.

Key estimates relate primarily to determining the net realizable value and demand for inventory, useful lives associated with property and equipment and intangible assets, valuation allowances with respect to deferred tax assets, contingencies, self-insurance accruals, evaluation of sales tax positions, and the valuation and assumptions underlying share-based compensation and equity warrants. On an ongoing basis, management evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents. Cash equivalents primarily consist of institutional money market funds, U.S. Treasury securities, certificates of deposit, and commercial paper and are carried at cost, which approximates fair value.

Concentration of Credit Risk

The Company maintains the majority of its cash and cash equivalents in accounts with large financial institutions. At times, balances in these accounts may exceed federally insured limits; however, to date, the Company has not incurred any losses on its deposits of cash and cash equivalents.

Investments

The Company generally invests its excess cash in AAA-rated money market funds and investment grade short- to intermediate-term fixed income securities, including U.S. Treasury securities, certificates of deposit, and commercial paper. Such investments are included in cash and cash equivalents or marketable securities on the accompanying consolidated balance sheets and are classified based on original maturity. The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents and considers all highly liquid investments with an original maturity greater than 90 days and less than one year to be marketable securities.

Marketable fixed income securities are classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive income (loss). Each reporting period, the Company evaluates whether declines in fair value below carrying value are due to expected credit losses, as well as its ability and intent to hold the investment until a forecasted recovery of the carrying value occurs. Expected credit losses are recorded as an allowance through other income (expense), net on the Company’s consolidated statements of operations.

Equity investments in public companies that have readily determinable fair values are included in marketable securities on the Company’s consolidated balance sheets and measured at fair value with changes recognized in other income (expense), net on the Company’s consolidated statements of operations.
The Company holds equity warrants giving it the right to acquire stock of other companies. These warrants are classified as derivative assets and are recorded within other non-current assets on the Company’s consolidated balance sheets with gains and losses recognized in other income (expense), net on the Company’s consolidated statements of operations. These warrants are subject to vesting requirements and the fair value established at contract inception is recognized as a deferred credit reported within other long-term liabilities on the Company’s consolidated balance sheets and is amortized as the vesting requirements are achieved. For more information, see Note 4 - Financial Instruments.

Accounts Receivable

The Company’s accounts receivable are comprised of customer and vendor receivables. The Company’s net customer receivables were $110.0 million and $105.2 million as of January 28, 2024 and January 29, 2023, respectively, and consist of credit and debit card receivables from banks, which typically settle within five business days. The Company’s vendor receivables were $44.0 million and $21.8 million as of January 28, 2024 and January 29, 2023, respectively. The Company does not maintain an allowance for doubtful accounts as neither historical losses on customer and vendor receivables nor future projected losses on such receivables have been or are expected to be significant.

Inventories

The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value.

Inventory costs consist of product and inbound shipping and handling costs. Inventory valuation requires the Company to make judgments, based on currently available information, about the likely method of disposition, such as through sales to individual customers or returns to product vendors. Inventory valuation losses are recorded as cost of goods sold and historical losses have not been significant.

Property and Equipment, net

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated over the estimated useful lives of the related assets using the straight-line method. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the remaining lease term (including renewals that are reasonably assured) or the estimated useful lives of the improvements. For software application projects which develop new software or enhance existing licensed or internally-developed software, external costs and certain internal costs, including payroll and payroll-related costs of employees, directly associated with developing these software applications for internal use are capitalized subsequent to the preliminary stage of development. Internal-use software costs are amortized using the straight-line method over the estimated useful life of the software when the project is substantially complete and ready for its intended use.

The estimated useful lives of property and equipment are principally as follows:
Furniture, fixtures and equipment
 5 to 10 years
Computer equipment and software
 3 to 5 years
Leasehold improvements and finance lease assetsShorter of the lease term or estimated useful life

Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gains or losses are included in the Company’s results of operations for the respective period. For more information, see Note 5 - Property and Equipment, net.
Leases

The Company has operating and finance lease agreements for its fulfillment and customer service centers, corporate offices, and certain equipment. The Company determines if an arrangement contains a lease at inception based on the ability to control a physically distinct asset. Operating and finance lease right-of-use assets are recorded in the consolidated balance sheets based on the initial measurement of the lease liability as adjusted to include prepaid rent and initial direct costs less any lease incentives received. Lease liabilities are measured at the commencement date based on the present value of the lease payments over the lease term. Lease payments are generally fixed but may include provisions for future rent increases based on a market index. The Company separately accounts for lease and non-lease components within lease agreements; the non-lease components primarily relate to common area maintenance for real estate leases. The Company uses its incremental borrowing rate to present value the lease liability as key inputs to determine the interest rate implicit in the lease are not shared by lessors.

Operating lease expense is recorded on a straight-line basis over the lease term. Right-of-use assets and lease liabilities for short-term leases are not recognized in the consolidated balance sheets. Payments for short-term leases are recognized in the consolidated statements of operations on a straight-line basis over the lease term.

Goodwill

Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. Goodwill is not amortized. The Company evaluates goodwill for impairment annually or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. The Company has the option to first perform a qualitative assessment of its goodwill to determine whether it is necessary to perform a quantitative impairment test. If the Company concludes via the qualitative assessment that it is more likely than not that goodwill is impaired, management performs the quantitative impairment test to evaluate the recoverability of goodwill by comparing the carrying value of the Company’s reporting units to their fair values. An impairment charge is recorded for the amount by which the carrying amounts exceed the fair values of the reporting units, with the loss recognized not exceeding the total amount of goodwill. The Company did not record any goodwill impairment during the periods presented.

Intangible Assets

Intangible assets are recognized and recorded at their acquisition date fair values. Intangible assets are amortized on a straight-line basis over their estimated useful lives with amortization expense included within selling, general and administrative expenses in the consolidated statements of operations. The Company determined the useful lives of its intangible assets based on multiple factors including obsolescence and the period over which expected cash flows are used to measure the fair value of the intangible asset at acquisition. The Company periodically reassesses the useful lives of its intangible assets when events or circumstances indicate that useful lives have significantly changed from the previous estimate. Intangible assets, net of accumulated amortization, are included within other non-current assets on the consolidated balance sheets.

The estimated useful lives of intangible assets are as follows:
Developed technology
3 years

Impairment of Long-Lived Assets

The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Conditions that would necessitate an impairment assessment include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used, or any other significant adverse change that would indicate that the carrying amount of an asset or group of assets may not be recoverable. For asset groups held and used, the carrying value of the asset group is considered recoverable when the estimated undiscounted future cash flows expected to be generated from the use and eventual disposition of the asset group exceed the respective carrying value. In the event that the carrying value is not considered recoverable, an impairment charge would be recognized for the asset group to be held and used equal to the excess of the carrying value above the estimated fair value of the asset group. Impairment charges are recognized within selling, general and administrative expenses in the consolidated statements of operations. Impairment charges recorded by the Company were not material for Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021.
Accrued Expenses and Other Current Liabilities

The following table presents the components of accrued expenses and other current liabilities (in thousands):

As of
January 28, 2024January 29, 2023
Outbound fulfillment$491,251 $370,095 
Advertising and marketing106,339 99,593 
Payroll liabilities83,880 66,799 
Accrued expenses and other324,467 258,047 
Total accrued expenses and other current liabilities$1,005,937 $794,534 

Self-Insurance Accruals

The Company uses a combination of self-insurance programs and large-deductible purchased insurance to provide for the costs of medical and workers’ compensation claims. The Company periodically evaluates its level of insurance coverage and adjusts its insurance levels based on risk tolerance and premium expense. Liabilities for the risks the Company retains, including estimates of claims incurred but not reported, are not discounted and are estimated, in part, by considering historical cost experience, demographic and severity factors, and judgments about current and expected levels of cost per claim and retention levels. Additionally, claims may emerge in future years for events that occurred in a prior year at a rate that differs from previous actuarial projections. The Company believes the actuarial methods are appropriate for measuring these self-insurance accruals. However, based on the number of claims and the length of time from incurrence of the claims to ultimate settlement, the use of any estimation method is sensitive to the assumptions and factors described above. Accordingly, changes in these assumptions and factors can affect the estimated liability and those amounts may be different than the actual costs paid to settle the claims.

Defined Contribution Plans

The Company maintains a 401(k) defined contribution plan which covers all employees who meet minimum requirements and elect to participate. The Company is currently matching employee contributions, up to specified percentages of those contributions.

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value:

Level 1-Valuations based on quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2-Valuations based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3-Valuations based on unobservable inputs reflecting the Company’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

The carrying amounts of the Company’s cash and cash equivalents, accounts receivable, trade accounts payable, and accrued expenses and other current liabilities approximate fair value based on the short-term maturities of these instruments.
Loss Contingencies

Certain conditions may exist which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities and such assessments inherently involve an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is estimable, the liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed. Unasserted claims that are not considered probable of being asserted and those for which an unfavorable outcome is not reasonably possible have not been disclosed.

Revenue Recognition

Chewy recognizes revenues from product sales when the customer orders an item through Chewy’s websites or mobile applications via the electronic shopping cart, funds are collected from the customer and the item is shipped from one of the Company’s fulfillment centers and delivered to the carrier. Certain products are shipped directly from manufacturers to Chewy customers. For all of the preceding, the Company is considered to be a principal to these transactions and revenue is recognized on a gross basis as the Company is (i) the primary entity responsible for fulfilling the promise to provide the specified products in the arrangement with the customer and provides the primary customer service for all products sold on Chewy’s websites or mobile applications, (ii) has inventory risk before the products have been transferred to a customer and maintains inventory risk upon accepting returns, and (iii) has discretion in establishing the price for the specified products sold on Chewy’s websites or mobile applications.

Chewy primarily generates net sales from sales of pet food, pet products, pet medications and other pet health products, and related shipping fees. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. To encourage customers to purchase its products, the Company periodically provides incentive offers. Generally, these promotions include current discount offers, such as percentage discounts off current purchases and other similar offers. These offers, when accepted by customers, are treated as a reduction to the transaction price. Revenue typically consists of the consideration received from the customer when the order is executed less a refund allowance, which is estimated using historical experience.

Taxes collected from customers for remittance to governmental authorities are excluded from net sales.

Cost of Goods Sold

Cost of goods sold includes the purchase price of inventory sold, freight costs associated with inventory, shipping supply costs, inventory shrinkage costs and valuation adjustments and reductions for promotions and discounts offered by the Company’s vendors.

Vendor Rebates

The Company has agreements with vendors to receive either percentage or volume rebates. Additionally, certain vendors provide funding for discounts relating to the Autoship subscription program which are passed on to the Company’s customers. The Company primarily receives agreed upon percentage rebates from vendors, however, certain of its vendor rebates are dependent upon reaching minimum purchase thresholds. In these instances, the Company evaluates the likelihood of reaching purchase thresholds using past experience and current year forecasts. When volume rebates can be reasonably estimated and it is probable that minimum purchase thresholds will be met, the Company records a portion of the rebate as it makes progress towards the purchase threshold. The Company also receives vendor funding in the form of advertising agreements related to general marketing activities. Amounts received from vendors are considered a reduction of the carrying value of the Company’s inventory and, therefore, such amounts are ultimately recorded as a reduction of cost of goods sold in the consolidated statements of operations.
Vendor Concentration Risk

The Company purchases inventory from several hundred vendors worldwide. Sales of products from the Company’s three largest vendors represented approximately 39%, 38%, and 35% of the Company’s net sales for Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, respectively.

Selling, General and Administrative

Selling, general and administrative expenses consist of payroll and related expenses for employees involved in general corporate functions, including accounting, finance, tax, legal, and human resources; costs associated with use by these functions of facilities and equipment, such as depreciation expense and rent; share-based compensation expense, professional fees and other general corporate costs.

Fulfillment

Fulfillment costs represent those costs incurred in operating and staffing fulfillment and customer service centers, including costs attributable to buying, receiving, inspecting and warehousing inventories, picking, packaging and preparing customer orders for shipment, payment processing, and responding to inquiries from customers. For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021 the Company recorded fulfillment costs of $1.3 billion, $1.2 billion, and $1.2 billion, respectively, which are included within selling, general and administrative expenses in the consolidated statements of operations. Included within fulfillment costs are merchant processing fees charged by third parties that provide merchant processing services for credit cards. For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, the Company recorded merchant processing fees of $234.0 million, $207.7 million, and $183.8 million, respectively, which are included within selling, general and administrative expenses in the consolidated statements of operations.

Share-Based Compensation

The Company recognizes share-based compensation expense based on the equity award’s grant date fair value. For grants of restricted stock units subject to service-based and company performance-based vesting conditions, the fair value is established based on the market price on the date of the grant. For grants of restricted stock units subject to market-based vesting conditions, the fair value is established using the Monte Carlo simulation lattice model. The determination of the fair value of share-based awards is affected by the Company’s stock price and a number of assumptions, including volatility, performance period, risk-free interest rate and expected dividends. The Company accounts for forfeitures as they occur. The grant date fair value of each restricted stock unit is amortized over the requisite service period.

Advertising and Marketing

Advertising and marketing expenses primarily consist of advertising and payroll and related expenses for personnel engaged in marketing, business development and selling activities. Advertising and marketing costs are expensed in the period that the advertising first takes place.

Interest Income (Expense), net

The Company generates interest income from its cash and cash equivalents and marketable securities and incurs interest expense from its borrowing facilities and finance leases. The following table provides additional information about the Company’s interest income (expense), net (in thousands):

Fiscal Year
202320222021
Interest income$62,083 $11,865 $523 
Interest expense(3,582)(2,575)(2,164)
Interest income (expense), net$58,501 $9,290 $(1,641)
Other Income (Expense), net

The Company’s other income (expense), net consists of changes in the fair value of equity warrants and investments, foreign currency transaction gains and losses, and allowances for credit losses. The following table provides additional information about the Company’s other income (expense), net (in thousands):

Fiscal Year
202320222021
Change in fair value of equity warrants$13,079 $(13,340)$— 
Foreign currency transaction gains285 174 — 
Change in fair value of equity investments(10)— — 
Other income (expense), net$13,354 $(13,166)$— 

Income and Other Taxes

Income taxes are accounted for under the asset and liability method, under which deferred tax assets and liabilities are recognized for the future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. The Company’s calculation relies on several factors, including pre-tax earnings and losses, differences between tax laws and accounting rules, statutory tax rates, uncertain tax positions, and valuation allowances. Valuation allowances are established when, in the Company’s judgment, it is more likely than not that its deferred tax assets will not be realized based on all available evidence. Management considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing tax planning strategies in assessing the need for a valuation allowance.

Chewy determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely than not that a position will be sustained, no amount of benefit attributable to the position is recognized. The tax benefit of any tax position that meets the more likely than not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the contingency. The Company records interest and penalties related to uncertain tax positions within interest expense and selling, general and administrative expenses, respectively, in the consolidated statements of operations.

The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes nexus exists. The Company maintains liabilities for potential exposure in states where taxability is uncertain and the Company did not collect sales tax.

Segments

Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.

Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. In September 2022, the FASB issued this Accounting Standards Update (“ASU”) which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period. This update became effective at the beginning of the Company’s 2023 fiscal year. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
Recently Issued Accounting Pronouncements

ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. In December 2023, the FASB issued this ASU to update income tax disclosure requirements, primarily related to the income tax rate reconciliation and income taxes paid information. This update is effective beginning with the Company’s 2025 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.
v3.24.1
Acquisitions
 12 Months Ended
Jan. 28, 2024
Business Combination and Asset Acquisition [Abstract]  
Acquisitions Acquisitions
Petabyte Acquisition

On October 23, 2022, the Company entered into a definitive Agreement and Plan of Merger (the “Petabyte Merger Agreement”) with Petabyte Technology Inc. (“Petabyte”), a Delaware corporation. Under the terms of the Petabyte Merger Agreement, the Company and Petabyte effected a merger on November 7, 2022, and Petabyte became a wholly-owned subsidiary of the Company. Headquartered in Bellevue, Washington, Petabyte is a provider of cloud-based technology solutions to the veterinary sector and the acquisition is expected to further strengthen the Company’s pet healthcare product and service offering.

The following table reconciles the purchase price to the cash paid for the acquisition, net of cash acquired (in thousands):

Purchase price$43,281 
Less: cash acquired2,881 
Cash paid for acquisition of business, net of cash acquired$40,400 

The Petabyte transaction was accounted for as a business combination in accordance with ASC 805 “Business Combinations.” Assets acquired and liabilities assumed were recorded in the accompanying consolidated balance sheet at their fair values, with the remaining unallocated purchase price recorded as goodwill. Goodwill represents the expected synergies and cost rationalization from the merger of operations as well as intangible assets that do not qualify for separate recognition such as an assembled workforce.

The following table summarizes the assets acquired and liabilities assumed as of the acquisition date (in thousands):

Assets acquired:
Cash and cash equivalents$2,881 
Accounts receivable104 
Goodwill39,442 
Identified intangible assets1,510 
Other current and non-current assets318 
Liabilities assumed:
Other current and long-term liabilities(974)
Purchase price$43,281 
Pro forma information for the Petabyte acquisition has not been provided as the impact was not material to the Company’s consolidated results of operations.

In connection with this acquisition the Company recorded goodwill of $39.4 million, none of which is anticipated to be deductible for tax purposes. The identified intangible assets consisted of $1.5 million of developed technology with an amortization period of 3.0 years.
v3.24.1
Financial Instruments
 12 Months Ended
Jan. 28, 2024
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments Financial Instruments
Cash equivalents are carried at cost, which approximates fair value and are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

Marketable securities are carried at fair value and are classified within Level 1 because they are valued using quoted market prices. Specific to marketable fixed income securities, the Company did not record any gross unrealized gains and losses as fair value approximates amortized cost. The Company did not record any credit losses during Fiscal Year 2023. Further, as of January 28, 2024, the Company did not record an allowance for credit losses related to its fixed income securities.

Equity investments in public companies that have readily determinable fair values are carried at fair value and are classified within Level 1 because they are valued using quoted market prices.

Equity warrants are classified within Level 3 because they are valued based on observable and unobservable inputs reflecting the Company’s assumptions, consistent with reasonably available assumptions made by other market participants. The Company utilized certain valuation techniques such as the Black-Scholes option-pricing model and the Monte Carlo simulation model to determine the fair value of equity warrants. The application of these models requires the use of a number of complex assumptions based on unobservable inputs, including the expected term, expected equity volatility, discounts for lack of marketability, cash flow projections, and probability with respect to vesting requirements.

The following table includes a summary of financial instruments measured at fair value as of January 28, 2024 (in thousands):

Level 1Level 2Level 3
Cash$602,232 $— $— 
Money market funds— — — 
Cash and cash equivalents602,232 — — 
U.S. Treasury securities531,592 — — 
Equity investments193 — — 
Marketable securities531,785 — — 
Equity warrants— — 2,219 
Total financial instruments$1,134,017 $— $2,219 

The following table includes a summary of financial instruments measured at fair value as of January 29, 2023 (in thousands):

Level 1Level 2Level 3
Cash$301,641 $— $— 
Money market funds30,000 — — 
Cash and cash equivalents331,641 — — 
U.S. Treasury securities346,926 — — 
Equity investments18 — — 
Marketable securities346,944 — — 
Equity warrants— — 31,622 
Total financial instruments$678,585 $— $31,622 
The following table summarizes the change in fair value for financial instruments using unobservable Level 3 inputs (in thousands):

Fiscal Year
20232022
Beginning balance$31,622 $— 
Equity warrants acquired— 44,962 
Change in fair value of equity warrants(29,403)(13,340)
Ending balance$2,219 $31,622 

As of January 28, 2024 and January 29, 2023, the deferred credit subject to vesting requirements recognized within other long-term liabilities in exchange for the equity warrants was $1.9 million and $45.0 million, respectively.

The following table presents quantitative information about Level 3 significant unobservable inputs used in the fair value measurement of the equity warrants as of January 28, 2024:

 Range
  Fair Value
(in thousands)		 Valuation Techniques Unobservable InputMinMaxWeighted Average
 Equity warrants$2,219 Black-Scholes and Monte Carlo Probability of vesting0%50%18%
Equity volatility35%85%77%
v3.24.1
Property and Equipment, net
 12 Months Ended
Jan. 28, 2024
Property, Plant and Equipment [Abstract]  
Property and Equipment, net Property and Equipment, net
The following is a summary of property and equipment, net (in thousands):

As of
January 28, 2024January 29, 2023
Furniture, fixtures and equipment$174,092 $162,618 
Computer equipment75,677 67,849 
Internal-use software183,380 139,082 
Leasehold improvements312,123 246,386 
Construction in progress82,014 93,535 
827,286 709,470 
Less: accumulated depreciation and amortization305,988 230,585 
Property and equipment, net$521,298 $478,885 

Internal-use software includes labor and license costs associated with software development for internal use. As of January 28, 2024 and January 29, 2023, the Company had accumulated amortization related to internal-use software of $87.5 million and $57.4 million, respectively.

Construction in progress is stated at cost, which includes the cost of construction and other directly attributable costs. No provision for depreciation is made on construction in progress until the relevant assets are completed and put into use.
For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, the Company recorded depreciation expense on property and equipment of $75.6 million, $57.5 million, and $40.8 million, respectively, and amortization expense related to internal-use software costs of $30.2 million, $22.4 million, and $14.2 million, respectively. The aforementioned depreciation and amortization expenses were included within selling, general and administrative expenses in the consolidated statements of operations.
v3.24.1
Identified Intangible Assets
 12 Months Ended
Jan. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Identified Intangible Assets Identified Intangible Assets
The following table provides information about the Company’s identified intangible assets (in thousands, except for weighted-average remaining life):

As of January 28, 2024
Gross Carrying AmountAccumulated AmortizationNet Carrying ValueWeighted-Average Remaining Life (years)
Developed technology $11,596 $(7,633)$3,963 1.0
Total intangible assets$11,596 $(7,633)$3,963 1.0

For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, the Company recorded amortization expense related to intangible assets of $3.9 million, $3.5 million, and $0.3 million, respectively. The future estimated amortization of intangible assets is as follows (in thousands):
Amortization Expense
2024$3,585 
2025378 
Total intangible asset amortization$3,963 
v3.24.1
Commitments and Contingencies
 12 Months Ended
Jan. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Matters
Various legal claims arise from time to time in the normal course of business. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

The Company believes that it has adequately accrued for the potential impact of loss contingencies that are probable and reasonably estimable. The Company does not believe that the ultimate resolution of any matters to which it is presently a party will have a material adverse effect on the Company’s results of operations, financial condition or cash flows. However, the results of these matters cannot be predicted with certainty, and an unfavorable resolution of one or more of these matters could have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

International Business Machines Corporation (“IBM”) previously alleged that the Company is infringing four of its patents. On February 15, 2021, the Company filed a declaratory judgment action in the United States District Court for the Southern District of New York (the “District Court”) against IBM seeking the District Court’s declaration that the Company is not infringing the four asserted IBM patents. On April 19, 2021, IBM filed an answer with counterclaims, seeking unspecified damages, including a request that the amount of compensatory damages be trebled, injunctive relief and costs and reasonable attorneys’ fees. On May 24, 2021, IBM filed an amended complaint that included an additional assertion that the Company is infringing a fifth IBM patent. On October 8, 2021, the parties had a claim construction hearing and on November 9, 2021, the claim construction rulings resulted in one of the five patents (the “‘414 patent”) being eliminated from the case.
The parties filed their motions for summary judgment which were fully briefed on February 24, 2022. On April 11, 2022, the District Court granted the Company’s motions for summary judgment that the Company did not infringe three of the patents and that the fourth patent is invalid. On April 29, 2022, IBM filed a notice of appeal in the United States Court of Appeals for the Federal Circuit (the “Federal Circuit”) to appeal the District Court’s judgment of non-infringement of certain of the patents. Oral argument for the appeal occurred on October 4, 2023 and a decision by the Federal Circuit was issued on March 5, 2024, which upheld the District Court’s decision except for a claim related to one of the patents (the “849 patent”), which has been remanded for further proceedings. Separately, on May 3, 2023, IBM sent the Company a letter indicating that the ‘414 patent that was invalidated by the District Court was reexamined by the U.S. Patent & Trademark Office and a reexamination certificate was issued. As a result, IBM is asserting that the Company infringes the new claims of the ‘414 patent. The Company continues to deny these allegations and all other allegations of any infringement and intends to vigorously defend itself in these matters.
v3.24.1
Debt
 12 Months Ended
Jan. 28, 2024
Debt Disclosure [Abstract]  
Debt Debt
ABL Credit Facility

The Company has a senior secured asset-based credit facility (the “ABL Credit Facility”) which matures on August 27, 2026 and provides for non-amortizing revolving loans in an aggregate principal amount of up to $800 million, subject to a borrowing base comprised of, among other things, inventory and sales receivables (subject to certain reserves). The ABL Credit Facility provides the right to request incremental commitments and add incremental asset-based revolving loan facilities in an aggregate principal amount of up to $250 million, subject to customary conditions.

Borrowings under the ABL Credit Facility bear interest at a rate per annum equal to an applicable margin, plus, at the Company’s option, either a base rate or a term Secured Overnight Financing Rate (“SOFR”). The applicable margin is generally determined based on the average excess liquidity during the immediately preceding fiscal quarter as a percentage of the maximum borrowing amount under the ABL Credit Facility, and is between 0.25% and 0.75% per annum for base rate loans and between 1.25% and 1.75% per annum for term SOFR loans. The Company is also required to pay a commitment fee of 0.25% per annum with respect to the undrawn portion of the commitments, which is generally based on average daily usage of the facility.

All obligations under the ABL Credit Facility are guaranteed on a senior secured first-lien basis by the Company’s wholly-owned domestic subsidiaries, subject to certain exceptions, and secured, subject to permitted liens and other exceptions, by a perfected first-priority security interest in substantially all of the Company’s and its wholly-owned domestic subsidiaries’ assets.

The ABL Credit Facility contains a number of covenants that, among other things, restrict the Company’s and its restricted subsidiaries’ ability to:
•incur or guarantee additional debt and issue certain equity securities;
•make certain investments and acquisitions;
•make certain restricted payments and payments of certain indebtedness;
•incur certain liens or permit them to exist;
•enter into certain types of transactions with affiliates;
•merge or consolidate with another company; and
•transfer, sell or otherwise dispose of assets.

Each of these restrictions is subject to various exceptions.
In addition, the ABL Credit Facility requires the Company to maintain a minimum fixed charge coverage ratio of 1.0:1.0 if excess liquidity under the facility is less than the greater of 10% of the maximum borrowing amount and $72.0 million for a certain period of time. The ABL Credit Facility also contains certain customary affirmative covenants and events of default for facilities of this type, including an event of default upon a change in control. Based on the Company’s borrowing base as of January 28, 2024, which is reduced by standby letters of credit, the Company had $759.0 million of borrowing capacity under the ABL Credit Facility. As of January 28, 2024, the Company had no outstanding borrowings under the ABL Credit Facility.
v3.24.1
Leases
 12 Months Ended
Jan. 28, 2024
Leases [Abstract]  
Leases Leases
The Company leases all of its fulfillment and customer service centers and corporate offices under non-cancelable operating lease agreements. The terms of the Company’s real estate leases generally range from 5 to 15 years and typically allow for the leases to be renewed for up to three additional five-year terms. Fulfillment and customer service centers and corporate office leases expire at various dates through 2038, excluding renewal options. The Company also leases certain equipment under operating and finance leases. The terms of equipment leases generally range from 3 to 5 years and do not contain renewal options. These leases expire at various dates through 2025.

The Company’s finance leases as of January 28, 2024 and January 29, 2023 were not material and were included in property and equipment, net, on the Company’s consolidated balance sheets.

The table below presents the operating lease-related assets and liabilities recorded on the consolidated balance sheets (in thousands):

As of
LeasesBalance Sheet ClassificationJanuary 28, 2024January 29, 2023
Assets
OperatingOperating lease right-of-use assets$474,617 $423,518 
Total operating lease assets$474,617 $423,518 
Liabilities
Current
OperatingAccrued expenses and other current liabilities$29,003 $27,646 
Non-current
OperatingOperating lease liabilities527,795 471,821 
Total operating lease liabilities$556,798 $499,467 

For Fiscal Year 2023 and Fiscal Year 2022, assets acquired in exchange for new operating lease liabilities were $106.3 million and $92.1 million, respectively. Lease expense primarily related to operating lease costs and were included within selling, general and administrative expenses in the consolidated statements of operations. For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, the Company recorded lease expense of $104.4 million, $90.9 million, and $79.7 million of which short-term and variable lease payments were $24.8 million, $18.9 million, and $17.7 million respectively.

As of January 28, 2024, the weighted-average remaining lease term and weighted-average discount rate for operating leases was 11.8 years and 8.4%, respectively. As of January 29, 2023, the weighted-average remaining lease term and weighted-average discount rate for operating leases was 12.0 years and 8.4%, respectively.

Cash flows used in operating activities related to operating leases were approximately $95.7 million, $76.8 million, and $67.9 million for Fiscal Years 2023, 2022, and 2021, respectively.
The table below presents the maturity of lease liabilities as of January 28, 2024 (in thousands):

Operating Leases
2024$70,522 
202577,677 
202674,844 
202770,932 
202871,866 
Thereafter534,553 
Total lease payments900,394 
Less: interest343,596 
Present value of lease liabilities$556,798 

The Company maintains arrangements with certain local government agencies which provide for certain ad valorem tax incentives in connection with the Company’s capital investment in property, plant, and equipment purchases to outfit new facilities over a specified timeframe. To facilitate the incentives, the Company conveys the purchased equipment to the local government agency and will lease the equipment from such agency for nominal consideration. Upon termination of the lease, including early termination, the equipment will be conveyed to the Company for a nominal fee.
v3.24.1
Stockholders’ Equity (Deficit)
 12 Months Ended
Jan. 28, 2024
Equity [Abstract]  
Stockholders’ Equity (Deficit) Stockholders’ Equity (Deficit)
Common Stock

Voting Rights

Holders of the Company’s Class A and Class B common stock are entitled to vote together as a single class on all matters submitted to a vote or for the consent of the stockholders of the Company, unless otherwise required by law or the Company’s amended and restated certificate of incorporation. Holders of Class A common stock are entitled to one vote per share and holders of Class B common stock are entitled to ten votes per share.

Dividends

Subject to the preferences applicable to any series of preferred stock, if any, outstanding, holders of Class A and Class B common stock are entitled to share equally, on a per share basis, in dividends and other distributions of cash, property or securities of the Company.

Liquidation

Subject to the preferences applicable to any series of preferred stock, if any, outstanding, in the event of the voluntary or involuntary liquidation, dissolution, distribution of assets or winding up of the Company, all assets of the Company available for distribution to common stockholders would be divided among and paid ratably to holders of Class A and Class B common stock.

Conversion of Class B Common Stock

Voluntary Conversion

Each share of Class B common stock is convertible into one fully paid and nonassessable share of Class A common stock at the option of the holder thereof with the prior written consent of the Company.

On May 8, 2020, Buddy Chester Sub LLC, a wholly-owned subsidiary of the Sponsors, converted 17,584,098 shares of the Company’s Class B common stock into Class A common stock. On May 11, 2020, Buddy Chester Sub LLC entered into a variable forward purchase agreement (the “Contract”) to deliver up to 17,584,098 shares of the Company’s Class A common stock at the exchange date, with the number of shares to be issued based on the trading price of the Company’s common stock during a 20-day observation period. On each of May 15, 2023 and May 16, 2023, Buddy Chester Sub LLC settled its obligations under the Contract and delivered a total of 17,584,098 shares.
On April 12, 2021, Argos Intermediate Holdco I Inc. (“Argos Holdco”) converted 6,150,000 shares of the Company’s Class B common stock into Class A common stock and sold such Class A common stock.

On January 9, 2024, Buddy Chester Sub LLC converted 12,325,000 shares of the Company’s Class B common stock into Class A common stock and sold such Class A common stock.

Automatic Conversion

All shares of Class B common stock shall automatically, without further action by any holder, be converted into an identical number of shares of fully paid and nonassessable Class A common stock (i) on the first trading day on or after the date on which the outstanding shares of Class B common stock constitute less than 7.5% of the aggregate number of shares of common stock then outstanding, or (ii) upon the occurrence of an event, specified by the affirmative vote (or written consent) of the holders of a majority of the then-outstanding shares of Class B common stock, voting as a separate class.

In addition, each share of Class B common stock will convert automatically into one share of Class A common stock (i) upon the sale or transfer of such share of Class B common stock, except for certain transfers described in the Company’s amended and restated certificate of incorporation, including transfers to affiliates of the holder and another holder of Class B common stock, or (ii) if the holder is not an affiliate of any of the Sponsors.

Preferred Stock

Preferred stock may be issued from time to time by the Company for such consideration as may be fixed by the board of directors. Except as otherwise required by law, holders of any series of preferred stock shall be entitled to only such voting rights, if any, as shall expressly be granted by the Company’s amended and restated certificate of incorporation (including any certificate of designation relating to such series of preferred stock).
v3.24.1
Share-Based Compensation
 12 Months Ended
Jan. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
2022 Omnibus Incentive Plan

In July 2022, the Company’s stockholders approved the Chewy, Inc. 2022 Omnibus Incentive Plan (the “2022 Plan”) replacing the Chewy, Inc. 2019 Omnibus Incentive Plan (the “2019 Plan”). The 2022 Plan became effective on July 14, 2022 and allows for the issuance of up to 40.0 million shares of Class A common stock and 1.0 million shares for new grants rolled over from the 2019 Plan. No awards may be granted under the 2022 Plan after July 2032. The 2022 Plan provides for the grants of: (i) options, including incentive stock options and non-qualified stock options, (ii) restricted stock units, (iii) other share-based awards, including share appreciation rights, phantom stock, restricted shares, performance shares, deferred share units, and share-denominated performance units, (iv) cash awards, (v) substitute awards, and (vi) dividend equivalents (collectively the “awards”). The awards may be granted to (i) the Company’s employees, consultants, and non-employee directors, (ii) employees of the Company’s affiliates and subsidiaries, and (iii) consultants of the Company’s subsidiaries.

Service and Performance-Based Awards

The Company granted restricted stock units which vested upon satisfaction of both service-based vesting conditions and company performance-based vesting conditions (“PRSUs”), subject to the employee’s continued employment with the Company through the applicable vesting date. The Company recorded share-based compensation expense for PRSUs over the requisite service period and accounted for forfeitures as they occur.
Service and Performance-Based Awards Activity

The following table summarizes the activity related to the Company’s PRSUs for Fiscal Year 2023 (in thousands, except for weighted average grant date fair value):

Number of PRSUsWeighted Average Grant Date Fair Value
Unvested and outstanding as of January 29, 20232,206 $36.22 
Granted500 $26.91 
Vested(1,936)$35.89 
Forfeited(217)$37.38 
Unvested and outstanding as of January 28, 2024553 $28.49 

The following table summarizes the weighted average grant-date fair value of PRSUs granted and total fair value of PRSUs vested for the periods presented:

Fiscal Year
202320222021
Weighted average grant-date fair value of PRSUs$26.91 $43.59 $80.85 
Total fair value of vested PRSUs (in millions)$74.8 $145.5 $318.2 

As of January 28, 2024, total unrecognized compensation expense related to unvested PRSUs was $13.7 million and is expected to be recognized over a weighted-average expected performance period of 2.0 years.

During Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, vesting occurred for 0.1 million, 0.2 million, and 0.2 million PRSUs, respectively, that were previously granted to an employee of PetSmart. For accounting purposes, the issuance of Class A common stock upon vesting of these PRSUs is treated as a distribution to a parent entity because both the Company and PetSmart are controlled by affiliates of BC Partners.

The fair value for PRSUs with a Company performance-based vesting condition is established based on the market price of the Company’s Class A common stock on the date of grant.

Service-Based Awards

The Company granted restricted stock units with service-based vesting conditions (“RSUs”) which vested subject to the employee’s continued employment with the Company through the applicable vesting date. The Company recorded share-based compensation expense for RSUs on a straight-line basis over the requisite service period and accounted for forfeitures as they occur.

Service-Based Awards Activity

The following table summarizes the activity related to the Company’s RSUs for Fiscal Year 2023 (in thousands, except for weighted average grant date fair value):

Number of RSUsWeighted Average Grant Date Fair Value
Unvested and outstanding as of January 29, 202310,813 $45.56 
Granted14,228 $31.00 
Vested(4,501)$45.61 
Forfeited(3,152)$39.94 
Unvested and outstanding as of January 28, 202417,388 $34.65 
The following table summarizes the weighted average grant-date fair value of RSUs granted and total fair value of RSUs vested for the periods presented:

Fiscal Year
202320222021
Weighted average grant-date fair value of RSUs$31.00 $41.54 $72.05 
Total fair value of vested RSUs (in millions)$154.6 $47.6 $19.5 

As of January 28, 2024, total unrecognized compensation expense related to unvested RSUs was $456.5 million and is expected to be recognized over a weighted-average expected performance period of 2.5 years.

The fair value for RSUs is established based on the market price of the Company’s Class A common stock on the date of grant.

As of January 28, 2024, there were 26.0 million additional shares of Class A common stock reserved for future issuance under the 2022 Plan.

Share-Based Compensation Expense

Share-based compensation expense is included within selling, general and administrative expenses in the consolidated statements of operations. The Company recognized share-based compensation expense as follows (in thousands):
Fiscal Year
202320222021
PRSUs$1,896 $12,710 $27,423 
RSUs237,211 145,412 50,349 
Total share-based compensation expense$239,107 $158,122 $77,772 
v3.24.1
Income Taxes
 12 Months Ended
Jan. 28, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Chewy is subject to taxation in the U.S. and various state, local, and foreign jurisdictions. Income taxes as presented in the Company’s consolidated financial statements have been prepared based on Chewy’s separate return method. As a result of the Transactions, the Company no longer files consolidated or combined state and local income tax returns with affiliates of BC Partners and no longer considers hypothetical net operating losses or credits associated with such income tax returns.

For Fiscal Year 2023 and Fiscal Year 2022, the Company recorded a current income tax provision of $8.7 million and $2.6 million, respectively. For Fiscal Year 2023 and Fiscal Year 2022, the Company’s income tax provisions for the foreign jurisdictions were not material. For Fiscal Year 2021, the Company did not have a current or deferred provision for income taxes for any taxing jurisdiction.
The Company’s effective income tax rate reconciliation is as follows for the periods presented:

Fiscal Year
202320222021
Federal statutory rate21.0 %21.0 %21.0 %
Foreign earnings, net of taxes2.8 %— %— %
State income taxes, net of federal tax benefit(4.1)%3.8 %10.9 %
Change in tax rate— %2.5 %(0.2)%
Share-based compensation and other nondeductible expenses16.8 %(24.4)%73.0 %
Tax credits(43.7)%(22.2)%36.1 %
Other0.9 %3.3 %(0.1)%
Change in valuation allowance24.2 %21.0 %(140.7)%
Effective rate17.9 %5.0 %— %

The temporary differences which comprise the Company’s deferred taxes are as follows for the periods presented (in thousands):
As of
January 28, 2024January 29, 2023
Deferred tax assets:
Operating lease liabilities $144,965 $129,786 
Inventories13,313 10,897 
Share-based compensation32,029 37,085 
Accrued expenses and reserves16,495 13,468 
Net operating loss carryforwards130,382 177,627 
Tax credit carryforwards52,166 40,391 
Capitalized research expenditures122,600 36,535 
Other3,248 7,971 
Total deferred tax assets515,198 453,760 
Less: valuation allowance281,119 230,692 
Deferred tax assets, net of valuation allowance234,079 223,068 
Deferred tax liabilities:
Operating lease right-of-use assets123,563 109,827 
Depreciation101,235 107,014 
Prepaids7,289 6,227 
Other1,992 — 
Total deferred tax liabilities234,079 223,068 
Net deferred tax assets$— $— 

Valuation Allowance

The valuation allowance increased by $50.4 million during Fiscal Year 2023. The increase in the valuation allowance primarily relates to: (i) an increase of $44.6 million relating to current year activity, (ii) an increase of $4.6 million relating to an increase in federal tax credits, and (iii) an increase of $1.2 million relating to miscellaneous adjustments to the Company’s deferred tax assets and liabilities.

Beginning in 2022, the 2017 Tax Cuts and Jobs Act (the “TCJA”) amended Section 174 to eliminate current-year deductibility of research and experimentation (“R&E”), and software development costs, and instead requires taxpayers to charge their R&E expenditures to a capital account amortized over five years (15 years for expenditures attributable to R&E activity performed outside the United States). As of January 28, 2024, the Company recorded deferred tax assets of $122.6 million, before any valuation allowance, with respect to capitalized R&E expenditures.
The ultimate realization of deferred tax assets depends on the generation of future taxable income during the periods in which those temporary differences are deductible. The Company considers the scheduled reversal of deferred tax liabilities (including the effect of available carryback and carryforward periods) in making this assessment. To fully utilize the net operating loss (“NOL”) and tax credit carryforwards the Company will need to generate sufficient future taxable income in each respective jurisdiction. Due to the Company’s history of losses, it is more likely than not that its deferred tax assets will not be realized as of January 28, 2024. Accordingly, the Company has established a full valuation allowance on its net deferred tax assets. A valuation allowance is recorded when it is more likely than not that some portion of the deferred tax assets will not be realized. To the extent that a valuation allowance has been established and it is subsequently determined that it is more likely than not that the deferred tax assets will be recovered, the valuation allowance will be released.

The following summarizes the activity related to valuation allowances on deferred tax assets (in thousands):
Fiscal Year
202320222021
Valuation allowance, as of beginning of period$230,692 $217,032 $124,012 
Valuation allowances established50,434 14,970 93,199 
Changes to existing valuation allowances(7)(1,310)(179)
Valuation allowance, as of end of period$281,119 $230,692 $217,032 
Net Operating Loss and Tax Credit Carryforwards

As of January 28, 2024, the Company had federal, state, and foreign NOL carryforwards of $492.7 million, $488.1 million and $20.4 million, respectively. The federal NOL carryforwards have no expiration and can only be used to offset 80% of the Company’s future taxable income. The state NOL carryforwards include $210.6 million with definitive expiration dates and $277.5 million with no expiration. The state NOLs are presented as an apportioned amount. The foreign NOL carryforwards have a 20-year expiration and can be used to offset 100% of the Company’s future taxable income.

As of January 28, 2024, the Company recorded deferred tax assets of $130.4 million, before any valuation allowance, with respect to federal and state NOL carryforwards. These deferred tax assets expire as follows (in thousands):

2024$91 
20253 
202664 
203213 
2033128 
Thereafter15,359 
Indefinite114,724 
Total loss carryforwards$130,382 

The Company participates in various federal and state credit programs which provide credits against current and future tax liabilities. Credits not used in the current year are carried forward to future years.
As of January 28, 2024, the Company recorded a deferred tax asset of $52.2 million, before any valuation allowance, with respect to federal and state tax credit carryforwards. These deferred tax assets expire as follows (in thousands):

Year of ExpirationResearch and DevelopmentWork OpportunityQuality Jobs Tax CreditTotal
2025$— $— $128 $128 
202690 — 183 273 
2027217 — 213 430 
203817 — — 17 
2040— 417 — 417 
20417,775 1,142 — 8,917 
204216,267 2,096 — 18,363 
204323,621 — — 23,621 
$47,987 $3,655 $524 $52,166 

Uncertain Tax Positions

In connection with the Transactions, the Company became obligor on $19.7 million of unrecognized tax benefits, inclusive of $1.4 million in interest through Fiscal Year 2023, which is fully indemnified by affiliates of BC Partners and will not have a material impact to the Company’s effective tax rate. The Company does not expect changes in the unrecognized tax benefits within the next 12 months that would have a material impact to its consolidated financial statements. The Company is no longer subject to U.S. state, or local tax examinations by tax authorities for years prior to Fiscal Year 2021 other than a few exceptions.

The following table provides a summary of gross unrecognized income tax benefits (in thousands):

Fiscal Year
202320222021
Beginning balance$— $— $— 
Additions due to parent reorganization transaction18,298 ——
Ending balance$18,298 $— $— 

Tax Sharing Agreement
The tax sharing agreement entered into between the Company, PetSmart, and Argos Holdco during Fiscal Year 2019 was terminated by all parties to the agreement on October 30, 2023 in connection with the Transactions. No remaining obligations exist between the parties.
During Fiscal Years 2023 and 2022, the Company paid $10.3 million and $2.8 million, respectively, pursuant to the tax sharing agreement. As of January 29, 2023, the Company had a payable related to the tax sharing agreement of $5.3 million.
Income Tax Payments and Liabilities

In connection with the Transactions, Chewy assumed $1.9 billion in income taxes which were fully indemnified by affiliates of BC Partners. During Fiscal Year 2023, the Company paid $1.8 billion in federal and state income taxes relating to the taxes assumed in connection with the Transactions and had an income tax payable of $108.9 million on such assumed income taxes as of January 28, 2024.

With respect to income taxes other than the Transactions, the Company paid $5.0 million in federal, state, and foreign income taxes during Fiscal Year 2023 and had an income tax payable of $4.4 million as of January 28, 2024.
Inflation Reduction Act
On August 16, 2022, the U.S enacted the Inflation Reduction Act which introduced new tax provisions, including a 15% corporate alternative minimum tax, a 1% excise tax on corporate stock buybacks, and several tax incentives to promote clean energy. These provisions did not have a material impact on the Company’s consolidated financial statements during Fiscal Year 2023 and the Company does not expect a material impact in future years.
v3.24.1
Earnings (Loss) per Share
 12 Months Ended
Jan. 28, 2024
Earnings Per Share [Abstract]  
Earnings (Loss) per Share Earnings (Loss) per Share
Basic and diluted earnings (loss) per share attributable to the Company’s common stockholders are presented using the two-class method required for participating securities. Under the two-class method, net income (loss) attributable to the Company’s common stockholders is determined by allocating undistributed earnings between common stock and participating securities. Undistributed earnings for the periods presented are calculated as net income (loss) less distributed earnings. Undistributed earnings are allocated proportionally to the Company’s common Class A and Class B stockholders as both classes are entitled to share equally, on a per share basis, in dividends and other distributions. Basic and diluted earnings (loss) per share are calculated by dividing net income (loss) attributable to the Company’s common stockholders by the weighted-average shares outstanding during the period.

The following table sets forth basic and diluted earnings (loss) per share attributable to the Company’s common stockholders for the periods presented (in thousands, except per share data):

Fiscal Year
202320222021
Basic and diluted earnings (loss) per share
Numerator
Earnings (loss) attributable to common Class A and Class B stockholders$39,580 $49,899 $(75,207)
Denominator
Weighted-average common shares used in computing earnings per share:
Basic429,457422,331417,218
Effect of dilutive share-based awards2,5835,439—
Diluted432,040427,770417,218
Anti-dilutive share-based awards excluded from diluted common shares11,0585,3779,773
Earnings (loss) per share attributable to common Class A and Class B stockholders:
Basic$0.09 $0.12 $(0.18)
Diluted$0.09 $0.12 $(0.18)
v3.24.1
Certain Relationships and Related Party Transactions
 12 Months Ended
Jan. 28, 2024
Related Party Transactions [Abstract]  
Certain Relationships and Related Party Transactions Certain Relationships and Related Party Transactions
As of January 28, 2024, the Company had a receivable from affiliates of BC Partners of $48.3 million with respect to the indemnification for certain tax liabilities in connection with the Transactions, which was included in prepaid expenses and other current assets on the Company’s consolidated balance sheets.

As of January 28, 2024, the Company did not have any amounts due to/from PetSmart. As of January 29, 2023, the Company had a net payable to PetSmart of $60.3 million, which was included in accrued expenses and other current liabilities on the Company’s consolidated balance sheets; the majority of this balance was extinguished as the result of a $54.7 million noncash settlement during Fiscal Year 2023.
v3.24.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Pay vs Performance Disclosure      
Net income (loss) $ 39,580 $ 49,899 $ (75,207)
v3.24.1
Insider Trading Arrangements
 3 Months Ended
Jan. 28, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.1
Basis of Presentation and Significant Accounting Policies (Policies)
 12 Months Ended
Jan. 28, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The Company’s accompanying consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) as set forth in the Financial Accounting Standards Board’s (“FASB”) accounting standards codification (“ASC”).

In connection with the Transactions described in Note 1 – Description of Business, the Company has provided restated consolidated financial statements and related notes for the historical comparative periods in this 10-K Report reflecting the operations of Chewy Pharmacy KY as part of the Company’s consolidated financial statements. This restatement was accounted for as a common control transaction, with Chewy Pharmacy KY’s net assets transferred at the previous parent company’s historical basis.
Fiscal Year
Fiscal Year

The Company has a 52- or 53-week fiscal year ending each year on the Sunday that is closest to January 31 of that year. The Company’s 2023 fiscal year ended January 28, 2024 and included 52 weeks (“Fiscal Year 2023”). The Company’s 2022 fiscal year ended January 29, 2023 and included 52 weeks (“Fiscal Year 2022”). The Company’s 2021 fiscal year ended January 30, 2022 and included 52 weeks (“Fiscal Year 2021”).
Principles of Consolidation
Principles of Consolidation
The consolidated financial statements and related notes include the accounts of Chewy, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates

GAAP requires management to make certain estimates, judgments, and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates these estimates and judgments. Actual results could differ from those estimates.

Key estimates relate primarily to determining the net realizable value and demand for inventory, useful lives associated with property and equipment and intangible assets, valuation allowances with respect to deferred tax assets, contingencies, self-insurance accruals, evaluation of sales tax positions, and the valuation and assumptions underlying share-based compensation and equity warrants. On an ongoing basis, management evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities.
Cash and Cash Equivalents
Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents. Cash equivalents primarily consist of institutional money market funds, U.S. Treasury securities, certificates of deposit, and commercial paper and are carried at cost, which approximates fair value.
Concentration of Credit Risk
Concentration of Credit Risk
The Company maintains the majority of its cash and cash equivalents in accounts with large financial institutions. At times, balances in these accounts may exceed federally insured limits; however, to date, the Company has not incurred any losses on its deposits of cash and cash equivalents.
Investments
Investments

The Company generally invests its excess cash in AAA-rated money market funds and investment grade short- to intermediate-term fixed income securities, including U.S. Treasury securities, certificates of deposit, and commercial paper. Such investments are included in cash and cash equivalents or marketable securities on the accompanying consolidated balance sheets and are classified based on original maturity. The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents and considers all highly liquid investments with an original maturity greater than 90 days and less than one year to be marketable securities.

Marketable fixed income securities are classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive income (loss). Each reporting period, the Company evaluates whether declines in fair value below carrying value are due to expected credit losses, as well as its ability and intent to hold the investment until a forecasted recovery of the carrying value occurs. Expected credit losses are recorded as an allowance through other income (expense), net on the Company’s consolidated statements of operations.

Equity investments in public companies that have readily determinable fair values are included in marketable securities on the Company’s consolidated balance sheets and measured at fair value with changes recognized in other income (expense), net on the Company’s consolidated statements of operations.
The Company holds equity warrants giving it the right to acquire stock of other companies. These warrants are classified as derivative assets and are recorded within other non-current assets on the Company’s consolidated balance sheets with gains and losses recognized in other income (expense), net on the Company’s consolidated statements of operations. These warrants are subject to vesting requirements and the fair value established at contract inception is recognized as a deferred credit reported within other long-term liabilities on the Company’s consolidated balance sheets and is amortized as the vesting requirements are achieved. For more information, see Note 4 - Financial Instruments.
Accounts Receivable
Accounts Receivable
The Company’s accounts receivable are comprised of customer and vendor receivables. The Company’s net customer receivables were $110.0 million and $105.2 million as of January 28, 2024 and January 29, 2023, respectively, and consist of credit and debit card receivables from banks, which typically settle within five business days. The Company’s vendor receivables were $44.0 million and $21.8 million as of January 28, 2024 and January 29, 2023, respectively. The Company does not maintain an allowance for doubtful accounts as neither historical losses on customer and vendor receivables nor future projected losses on such receivables have been or are expected to be significant.
Inventories
Inventories

The Company’s inventories represent finished goods, consist of products available for sale and are accounted for using the first-in, first-out (FIFO) method and valued at the lower of cost or net realizable value.
Inventory costs consist of product and inbound shipping and handling costs. Inventory valuation requires the Company to make judgments, based on currently available information, about the likely method of disposition, such as through sales to individual customers or returns to product vendors. Inventory valuation losses are recorded as cost of goods sold and historical losses have not been significant.
Property and Equipment, net
Property and Equipment, net

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated over the estimated useful lives of the related assets using the straight-line method. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the remaining lease term (including renewals that are reasonably assured) or the estimated useful lives of the improvements. For software application projects which develop new software or enhance existing licensed or internally-developed software, external costs and certain internal costs, including payroll and payroll-related costs of employees, directly associated with developing these software applications for internal use are capitalized subsequent to the preliminary stage of development. Internal-use software costs are amortized using the straight-line method over the estimated useful life of the software when the project is substantially complete and ready for its intended use.

The estimated useful lives of property and equipment are principally as follows:
Furniture, fixtures and equipment
 5 to 10 years
Computer equipment and software
 3 to 5 years
Leasehold improvements and finance lease assetsShorter of the lease term or estimated useful life

Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gains or losses are included in the Company’s results of operations for the respective period. For more information, see Note 5 - Property and Equipment, net.
Leases
Leases

The Company has operating and finance lease agreements for its fulfillment and customer service centers, corporate offices, and certain equipment. The Company determines if an arrangement contains a lease at inception based on the ability to control a physically distinct asset. Operating and finance lease right-of-use assets are recorded in the consolidated balance sheets based on the initial measurement of the lease liability as adjusted to include prepaid rent and initial direct costs less any lease incentives received. Lease liabilities are measured at the commencement date based on the present value of the lease payments over the lease term. Lease payments are generally fixed but may include provisions for future rent increases based on a market index. The Company separately accounts for lease and non-lease components within lease agreements; the non-lease components primarily relate to common area maintenance for real estate leases. The Company uses its incremental borrowing rate to present value the lease liability as key inputs to determine the interest rate implicit in the lease are not shared by lessors.

Operating lease expense is recorded on a straight-line basis over the lease term. Right-of-use assets and lease liabilities for short-term leases are not recognized in the consolidated balance sheets. Payments for short-term leases are recognized in the consolidated statements of operations on a straight-line basis over the lease term.
Goodwill
Goodwill

Goodwill represents the excess of the purchase price over the fair value of net assets acquired in a business combination. Goodwill is not amortized. The Company evaluates goodwill for impairment annually or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. The Company has the option to first perform a qualitative assessment of its goodwill to determine whether it is necessary to perform a quantitative impairment test. If the Company concludes via the qualitative assessment that it is more likely than not that goodwill is impaired, management performs the quantitative impairment test to evaluate the recoverability of goodwill by comparing the carrying value of the Company’s reporting units to their fair values. An impairment charge is recorded for the amount by which the carrying amounts exceed the fair values of the reporting units, with the loss recognized not exceeding the total amount of goodwill. The Company did not record any goodwill impairment during the periods presented.
Intangible Assets
Intangible Assets
Intangible assets are recognized and recorded at their acquisition date fair values. Intangible assets are amortized on a straight-line basis over their estimated useful lives with amortization expense included within selling, general and administrative expenses in the consolidated statements of operations. The Company determined the useful lives of its intangible assets based on multiple factors including obsolescence and the period over which expected cash flows are used to measure the fair value of the intangible asset at acquisition. The Company periodically reassesses the useful lives of its intangible assets when events or circumstances indicate that useful lives have significantly changed from the previous estimate. Intangible assets, net of accumulated amortization, are included within other non-current assets on the consolidated balance sheets.
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Conditions that would necessitate an impairment assessment include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used, or any other significant adverse change that would indicate that the carrying amount of an asset or group of assets may not be recoverable. For asset groups held and used, the carrying value of the asset group is considered recoverable when the estimated undiscounted future cash flows expected to be generated from the use and eventual disposition of the asset group exceed the respective carrying value. In the event that the carrying value is not considered recoverable, an impairment charge would be recognized for the asset group to be held and used equal to the excess of the carrying value above the estimated fair value of the asset group. Impairment charges are recognized within selling, general and administrative expenses in the consolidated statements of operations.
Self-Insurance Accruals
Self-Insurance Accruals

The Company uses a combination of self-insurance programs and large-deductible purchased insurance to provide for the costs of medical and workers’ compensation claims. The Company periodically evaluates its level of insurance coverage and adjusts its insurance levels based on risk tolerance and premium expense. Liabilities for the risks the Company retains, including estimates of claims incurred but not reported, are not discounted and are estimated, in part, by considering historical cost experience, demographic and severity factors, and judgments about current and expected levels of cost per claim and retention levels. Additionally, claims may emerge in future years for events that occurred in a prior year at a rate that differs from previous actuarial projections. The Company believes the actuarial methods are appropriate for measuring these self-insurance accruals. However, based on the number of claims and the length of time from incurrence of the claims to ultimate settlement, the use of any estimation method is sensitive to the assumptions and factors described above. Accordingly, changes in these assumptions and factors can affect the estimated liability and those amounts may be different than the actual costs paid to settle the claims.
Defined Contribution Plans
Defined Contribution Plans

The Company maintains a 401(k) defined contribution plan which covers all employees who meet minimum requirements and elect to participate. The Company is currently matching employee contributions, up to specified percentages of those contributions.
Fair Value of Financial Instruments
Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value:

Level 1-Valuations based on quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2-Valuations based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3-Valuations based on unobservable inputs reflecting the Company’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

The carrying amounts of the Company’s cash and cash equivalents, accounts receivable, trade accounts payable, and accrued expenses and other current liabilities approximate fair value based on the short-term maturities of these instruments.
Loss Contingencies
Loss Contingencies

Certain conditions may exist which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management assesses such contingent liabilities and such assessments inherently involve an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability is estimable, the liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed. Unasserted claims that are not considered probable of being asserted and those for which an unfavorable outcome is not reasonably possible have not been disclosed.
Revenue Recognition
Revenue Recognition

Chewy recognizes revenues from product sales when the customer orders an item through Chewy’s websites or mobile applications via the electronic shopping cart, funds are collected from the customer and the item is shipped from one of the Company’s fulfillment centers and delivered to the carrier. Certain products are shipped directly from manufacturers to Chewy customers. For all of the preceding, the Company is considered to be a principal to these transactions and revenue is recognized on a gross basis as the Company is (i) the primary entity responsible for fulfilling the promise to provide the specified products in the arrangement with the customer and provides the primary customer service for all products sold on Chewy’s websites or mobile applications, (ii) has inventory risk before the products have been transferred to a customer and maintains inventory risk upon accepting returns, and (iii) has discretion in establishing the price for the specified products sold on Chewy’s websites or mobile applications.

Chewy primarily generates net sales from sales of pet food, pet products, pet medications and other pet health products, and related shipping fees. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. To encourage customers to purchase its products, the Company periodically provides incentive offers. Generally, these promotions include current discount offers, such as percentage discounts off current purchases and other similar offers. These offers, when accepted by customers, are treated as a reduction to the transaction price. Revenue typically consists of the consideration received from the customer when the order is executed less a refund allowance, which is estimated using historical experience.
Taxes collected from customers for remittance to governmental authorities are excluded from net sales.
Cost of Goods Sold
Cost of Goods Sold

Cost of goods sold includes the purchase price of inventory sold, freight costs associated with inventory, shipping supply costs, inventory shrinkage costs and valuation adjustments and reductions for promotions and discounts offered by the Company’s vendors.

Vendor Rebates
The Company has agreements with vendors to receive either percentage or volume rebates. Additionally, certain vendors provide funding for discounts relating to the Autoship subscription program which are passed on to the Company’s customers. The Company primarily receives agreed upon percentage rebates from vendors, however, certain of its vendor rebates are dependent upon reaching minimum purchase thresholds. In these instances, the Company evaluates the likelihood of reaching purchase thresholds using past experience and current year forecasts. When volume rebates can be reasonably estimated and it is probable that minimum purchase thresholds will be met, the Company records a portion of the rebate as it makes progress towards the purchase threshold. The Company also receives vendor funding in the form of advertising agreements related to general marketing activities. Amounts received from vendors are considered a reduction of the carrying value of the Company’s inventory and, therefore, such amounts are ultimately recorded as a reduction of cost of goods sold in the consolidated statements of operations.
Selling, General and Administrative
Selling, General and Administrative

Selling, general and administrative expenses consist of payroll and related expenses for employees involved in general corporate functions, including accounting, finance, tax, legal, and human resources; costs associated with use by these functions of facilities and equipment, such as depreciation expense and rent; share-based compensation expense, professional fees and other general corporate costs.

Fulfillment
Fulfillment costs represent those costs incurred in operating and staffing fulfillment and customer service centers, including costs attributable to buying, receiving, inspecting and warehousing inventories, picking, packaging and preparing customer orders for shipment, payment processing, and responding to inquiries from customers. For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021 the Company recorded fulfillment costs of $1.3 billion, $1.2 billion, and $1.2 billion, respectively, which are included within selling, general and administrative expenses in the consolidated statements of operations. Included within fulfillment costs are merchant processing fees charged by third parties that provide merchant processing services for credit cards. For Fiscal Year 2023, Fiscal Year 2022, and Fiscal Year 2021, the Company recorded merchant processing fees of $234.0 million, $207.7 million, and $183.8 million, respectively, which are included within selling, general and administrative expenses in the consolidated statements of operations.
Share-Based Compensation
Share-Based Compensation

The Company recognizes share-based compensation expense based on the equity award’s grant date fair value. For grants of restricted stock units subject to service-based and company performance-based vesting conditions, the fair value is established based on the market price on the date of the grant. For grants of restricted stock units subject to market-based vesting conditions, the fair value is established using the Monte Carlo simulation lattice model. The determination of the fair value of share-based awards is affected by the Company’s stock price and a number of assumptions, including volatility, performance period, risk-free interest rate and expected dividends. The Company accounts for forfeitures as they occur. The grant date fair value of each restricted stock unit is amortized over the requisite service period.
Advertising and Marketing
Advertising and Marketing
Advertising and marketing expenses primarily consist of advertising and payroll and related expenses for personnel engaged in marketing, business development and selling activities. Advertising and marketing costs are expensed in the period that the advertising first takes place.
Interest Income (Expense), net
Interest Income (Expense), net
The Company generates interest income from its cash and cash equivalents and marketable securities and incurs interest expense from its borrowing facilities and finance leases.
Other Income (Expense), net
Other Income (Expense), net
The Company’s other income (expense), net consists of changes in the fair value of equity warrants and investments, foreign currency transaction gains and losses, and allowances for credit losses.
Income and Other Taxes
Income and Other Taxes

Income taxes are accounted for under the asset and liability method, under which deferred tax assets and liabilities are recognized for the future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. The Company’s calculation relies on several factors, including pre-tax earnings and losses, differences between tax laws and accounting rules, statutory tax rates, uncertain tax positions, and valuation allowances. Valuation allowances are established when, in the Company’s judgment, it is more likely than not that its deferred tax assets will not be realized based on all available evidence. Management considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing tax planning strategies in assessing the need for a valuation allowance.

Chewy determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely than not that a position will be sustained, no amount of benefit attributable to the position is recognized. The tax benefit of any tax position that meets the more likely than not recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the contingency. The Company records interest and penalties related to uncertain tax positions within interest expense and selling, general and administrative expenses, respectively, in the consolidated statements of operations.

The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes nexus exists. The Company maintains liabilities for potential exposure in states where taxability is uncertain and the Company did not collect sales tax.
Segments
Segments
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Recent Accounting Pronouncements
Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. In September 2022, the FASB issued this Accounting Standards Update (“ASU”) which requires entities that use supplier finance programs in connection with the purchase of goods and services to disclose the key terms of the programs and information about obligations outstanding at the end of the reporting period. This update became effective at the beginning of the Company’s 2023 fiscal year. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
Recently Issued Accounting Pronouncements

ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. In December 2023, the FASB issued this ASU to update income tax disclosure requirements, primarily related to the income tax rate reconciliation and income taxes paid information. This update is effective beginning with the Company’s 2025 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.

ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. In November 2023, the FASB issued this ASU to update reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. This update is effective beginning with the Company’s 2024 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.

ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. In June 2022, the FASB issued this ASU to clarify the guidance when measuring the fair value of an equity security subject to contractual sale restrictions that prohibit the sale of an equity security. This update is effective at the beginning of the Company’s 2024 fiscal year, with early adoption permitted. The Company does not believe the adoption of this standard will have a material impact on its consolidated financial statements.
v3.24.1
Basis of Presentation and Significant Accounting Policies (Tables)
 12 Months Ended
Jan. 28, 2024
Accounting Policies [Abstract]  
Estimated Useful Lives of Property and Equipment
The estimated useful lives of property and equipment are principally as follows:
Furniture, fixtures and equipment
 5 to 10 years
Computer equipment and software
 3 to 5 years
Leasehold improvements and finance lease assetsShorter of the lease term or estimated useful life
The following is a summary of property and equipment, net (in thousands):

As of
January 28, 2024January 29, 2023
Furniture, fixtures and equipment$174,092 $162,618 
Computer equipment75,677 67,849 
Internal-use software183,380 139,082 
Leasehold improvements312,123 246,386 
Construction in progress82,014 93,535 
827,286 709,470 
Less: accumulated depreciation and amortization305,988 230,585 
Property and equipment, net$521,298 $478,885 
Estimated Useful Lives of Intangible Assets
The estimated useful lives of intangible assets are as follows:
Developed technology
3 years
The following table provides information about the Company’s identified intangible assets (in thousands, except for weighted-average remaining life):

As of January 28, 2024
Gross Carrying AmountAccumulated AmortizationNet Carrying ValueWeighted-Average Remaining Life (years)
Developed technology $11,596 $(7,633)$3,963 1.0
Total intangible assets$11,596 $(7,633)$3,963 1.0
Schedule of Accrued Expenses and Other Current Liabilities
The following table presents the components of accrued expenses and other current liabilities (in thousands):

As of
January 28, 2024January 29, 2023
Outbound fulfillment$491,251 $370,095 
Advertising and marketing106,339 99,593 
Payroll liabilities83,880 66,799 
Accrued expenses and other324,467 258,047 
Total accrued expenses and other current liabilities$1,005,937 $794,534 
Schedule of Interest Income and Expense The following table provides additional information about the Company’s interest income (expense), net (in thousands):
Fiscal Year
202320222021
Interest income$62,083 $11,865 $523 
Interest expense(3,582)(2,575)(2,164)
Interest income (expense), net$58,501 $9,290 $(1,641)
Schedule of Other Nonoperating Income (Expense) The following table provides additional information about the Company’s other income (expense), net (in thousands):
Fiscal Year
202320222021
Change in fair value of equity warrants$13,079 $(13,340)$— 
Foreign currency transaction gains285 174 — 
Change in fair value of equity investments(10)— — 
Other income (expense), net$13,354 $(13,166)$— 
v3.24.1
Acquisitions (Tables)
 12 Months Ended
Jan. 28, 2024
Business Combination and Asset Acquisition [Abstract]  
Schedule of Estimated Purchase Price, Net of Cash Acquired
The following table reconciles the purchase price to the cash paid for the acquisition, net of cash acquired (in thousands):

Purchase price$43,281 
Less: cash acquired2,881 
Cash paid for acquisition of business, net of cash acquired$40,400 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the assets acquired and liabilities assumed as of the acquisition date (in thousands):

Assets acquired:
Cash and cash equivalents$2,881 
Accounts receivable104 
Goodwill39,442 
Identified intangible assets1,510 
Other current and non-current assets318 
Liabilities assumed:
Other current and long-term liabilities(974)
Purchase price$43,281 
v3.24.1
Financial Instruments (Tables)
 12 Months Ended
Jan. 28, 2024
Investments, Debt and Equity Securities [Abstract]  
Summary of Cash and Cash Equivalents
The following table includes a summary of financial instruments measured at fair value as of January 28, 2024 (in thousands):

Level 1Level 2Level 3
Cash$602,232 $— $— 
Money market funds— — — 
Cash and cash equivalents602,232 — — 
U.S. Treasury securities531,592 — — 
Equity investments193 — — 
Marketable securities531,785 — — 
Equity warrants— — 2,219 
Total financial instruments$1,134,017 $— $2,219 

The following table includes a summary of financial instruments measured at fair value as of January 29, 2023 (in thousands):

Level 1Level 2Level 3
Cash$301,641 $— $— 
Money market funds30,000 — — 
Cash and cash equivalents331,641 — — 
U.S. Treasury securities346,926 — — 
Equity investments18 — — 
Marketable securities346,944 — — 
Equity warrants— — 31,622 
Total financial instruments$678,585 $— $31,622 
Summary of Changes in Fair Value for Financial Instruments Using Unobservable Level 3 Inputs
The following table summarizes the change in fair value for financial instruments using unobservable Level 3 inputs (in thousands):

Fiscal Year
20232022
Beginning balance$31,622 $— 
Equity warrants acquired— 44,962 
Change in fair value of equity warrants(29,403)(13,340)
Ending balance$2,219 $31,622 
Fair Value Measurement Valuation Assumptions
The following table presents quantitative information about Level 3 significant unobservable inputs used in the fair value measurement of the equity warrants as of January 28, 2024:

 Range
  Fair Value
(in thousands)		 Valuation Techniques Unobservable InputMinMaxWeighted Average
 Equity warrants$2,219 Black-Scholes and Monte Carlo Probability of vesting0%50%18%
Equity volatility35%85%77%
v3.24.1
Property and Equipment, net (Tables)
 12 Months Ended
Jan. 28, 2024
Property, Plant and Equipment [Abstract]  
Summary of Property and Equipment, Net
The estimated useful lives of property and equipment are principally as follows:
Furniture, fixtures and equipment
 5 to 10 years
Computer equipment and software
 3 to 5 years
Leasehold improvements and finance lease assetsShorter of the lease term or estimated useful life
The following is a summary of property and equipment, net (in thousands):

As of
January 28, 2024January 29, 2023
Furniture, fixtures and equipment$174,092 $162,618 
Computer equipment75,677 67,849 
Internal-use software183,380 139,082 
Leasehold improvements312,123 246,386 
Construction in progress82,014 93,535 
827,286 709,470 
Less: accumulated depreciation and amortization305,988 230,585 
Property and equipment, net$521,298 $478,885 
v3.24.1
Identified Intangible Assets (Tables)
 12 Months Ended
Jan. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets
The estimated useful lives of intangible assets are as follows:
Developed technology
3 years
The following table provides information about the Company’s identified intangible assets (in thousands, except for weighted-average remaining life):

As of January 28, 2024
Gross Carrying AmountAccumulated AmortizationNet Carrying ValueWeighted-Average Remaining Life (years)
Developed technology $11,596 $(7,633)$3,963 1.0
Total intangible assets$11,596 $(7,633)$3,963 1.0
Schedule of Future Estimated Amortization of Intangible Assets The future estimated amortization of intangible assets is as follows (in thousands):
Amortization Expense
2024$3,585 
2025378 
Total intangible asset amortization$3,963 
v3.24.1
Leases (Tables)
 12 Months Ended
Jan. 28, 2024
Leases [Abstract]  
Operating Lease-related Assets and Liabilities
The table below presents the operating lease-related assets and liabilities recorded on the consolidated balance sheets (in thousands):

As of
LeasesBalance Sheet ClassificationJanuary 28, 2024January 29, 2023
Assets
OperatingOperating lease right-of-use assets$474,617 $423,518 
Total operating lease assets$474,617 $423,518 
Liabilities
Current
OperatingAccrued expenses and other current liabilities$29,003 $27,646 
Non-current
OperatingOperating lease liabilities527,795 471,821 
Total operating lease liabilities$556,798 $499,467 
Maturity of Operating Lease liabilities
The table below presents the maturity of lease liabilities as of January 28, 2024 (in thousands):

Operating Leases
2024$70,522 
202577,677 
202674,844 
202770,932 
202871,866 
Thereafter534,553 
Total lease payments900,394 
Less: interest343,596 
Present value of lease liabilities$556,798 
v3.24.1
Share-Based Compensation (Tables)
 12 Months Ended
Jan. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Service and Performance Based-Awards Activity
The following table summarizes the activity related to the Company’s PRSUs for Fiscal Year 2023 (in thousands, except for weighted average grant date fair value):

Number of PRSUsWeighted Average Grant Date Fair Value
Unvested and outstanding as of January 29, 20232,206 $36.22 
Granted500 $26.91 
Vested(1,936)$35.89 
Forfeited(217)$37.38 
Unvested and outstanding as of January 28, 2024553 $28.49 
The following table summarizes the activity related to the Company’s RSUs for Fiscal Year 2023 (in thousands, except for weighted average grant date fair value):

Number of RSUsWeighted Average Grant Date Fair Value
Unvested and outstanding as of January 29, 202310,813 $45.56 
Granted14,228 $31.00 
Vested(4,501)$45.61 
Forfeited(3,152)$39.94 
Unvested and outstanding as of January 28, 202417,388 $34.65 
Summary of Weighted Average Grant-Date Fair Value and Total Fair Value of Service and Performance Based-Awards Activity
The following table summarizes the weighted average grant-date fair value of PRSUs granted and total fair value of PRSUs vested for the periods presented:

Fiscal Year
202320222021
Weighted average grant-date fair value of PRSUs$26.91 $43.59 $80.85 
Total fair value of vested PRSUs (in millions)$74.8 $145.5 $318.2 
The following table summarizes the weighted average grant-date fair value of RSUs granted and total fair value of RSUs vested for the periods presented:

Fiscal Year
202320222021
Weighted average grant-date fair value of RSUs$31.00 $41.54 $72.05 
Total fair value of vested RSUs (in millions)$154.6 $47.6 $19.5 
Schedule of Compensation Expense The Company recognized share-based compensation expense as follows (in thousands):
Fiscal Year
202320222021
PRSUs$1,896 $12,710 $27,423 
RSUs237,211 145,412 50,349 
Total share-based compensation expense$239,107 $158,122 $77,772 
v3.24.1
Income Taxes (Tables)
 12 Months Ended
Jan. 28, 2024
Income Tax Disclosure [Abstract]  
Effective Income Tax Rate Reconciliation
The Company’s effective income tax rate reconciliation is as follows for the periods presented:

Fiscal Year
202320222021
Federal statutory rate21.0 %21.0 %21.0 %
Foreign earnings, net of taxes2.8 %— %— %
State income taxes, net of federal tax benefit(4.1)%3.8 %10.9 %
Change in tax rate— %2.5 %(0.2)%
Share-based compensation and other nondeductible expenses16.8 %(24.4)%73.0 %
Tax credits(43.7)%(22.2)%36.1 %
Other0.9 %3.3 %(0.1)%
Change in valuation allowance24.2 %21.0 %(140.7)%
Effective rate17.9 %5.0 %— %
Schedule of Deferred Tax Assets and Liabilities
The temporary differences which comprise the Company’s deferred taxes are as follows for the periods presented (in thousands):
As of
January 28, 2024January 29, 2023
Deferred tax assets:
Operating lease liabilities $144,965 $129,786 
Inventories13,313 10,897 
Share-based compensation32,029 37,085 
Accrued expenses and reserves16,495 13,468 
Net operating loss carryforwards130,382 177,627 
Tax credit carryforwards52,166 40,391 
Capitalized research expenditures122,600 36,535 
Other3,248 7,971 
Total deferred tax assets515,198 453,760 
Less: valuation allowance281,119 230,692 
Deferred tax assets, net of valuation allowance234,079 223,068 
Deferred tax liabilities:
Operating lease right-of-use assets123,563 109,827 
Depreciation101,235 107,014 
Prepaids7,289 6,227 
Other1,992 — 
Total deferred tax liabilities234,079 223,068 
Net deferred tax assets$— $— 
Summary of Valuation Allowance
The following summarizes the activity related to valuation allowances on deferred tax assets (in thousands):
Fiscal Year
202320222021
Valuation allowance, as of beginning of period$230,692 $217,032 $124,012 
Valuation allowances established50,434 14,970 93,199 
Changes to existing valuation allowances(7)(1,310)(179)
Valuation allowance, as of end of period$281,119 $230,692 $217,032 
Summary of Operating Loss Carryforwards These deferred tax assets expire as follows (in thousands):
2024$91 
20253 
202664 
203213 
2033128 
Thereafter15,359 
Indefinite114,724 
Total loss carryforwards$130,382 
Summary of Tax Credit Carryforwards
As of January 28, 2024, the Company recorded a deferred tax asset of $52.2 million, before any valuation allowance, with respect to federal and state tax credit carryforwards. These deferred tax assets expire as follows (in thousands):

Year of ExpirationResearch and DevelopmentWork OpportunityQuality Jobs Tax CreditTotal
2025$— $— $128 $128 
202690 — 183 273 
2027217 — 213 430 
203817 — — 17 
2040— 417 — 417 
20417,775 1,142 — 8,917 
204216,267 2,096 — 18,363 
204323,621 — — 23,621 
$47,987 $3,655 $524 $52,166 
Schedule of Unrecognized Tax Benefits Roll Forward
The following table provides a summary of gross unrecognized income tax benefits (in thousands):

Fiscal Year
202320222021
Beginning balance$— $— $— 
Additions due to parent reorganization transaction18,298 ——
Ending balance$18,298 $— $— 
v3.24.1
Earnings (Loss) per Share (Tables)
 12 Months Ended
Jan. 28, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings (Loss) Per Share
The following table sets forth basic and diluted earnings (loss) per share attributable to the Company’s common stockholders for the periods presented (in thousands, except per share data):

Fiscal Year
202320222021
Basic and diluted earnings (loss) per share
Numerator
Earnings (loss) attributable to common Class A and Class B stockholders$39,580 $49,899 $(75,207)
Denominator
Weighted-average common shares used in computing earnings per share:
Basic429,457422,331417,218
Effect of dilutive share-based awards2,5835,439—
Diluted432,040427,770417,218
Anti-dilutive share-based awards excluded from diluted common shares11,0585,3779,773
Earnings (loss) per share attributable to common Class A and Class B stockholders:
Basic$0.09 $0.12 $(0.18)
Diluted$0.09 $0.12 $(0.18)
v3.24.1
Description of Business (Details)
$ in Billions
 12 Months Ended
Oct. 30, 2023
USD ($)
Jan. 28, 2024
vote
Class of Stock [Line Items]    
Related party transaction, maximum stockholder percentage 50.00%  
Related party transaction, amounts of transaction | $ $ 1.9  
Class B Common Stock    
Class of Stock [Line Items]    
Common stock number of votes per share   10
Class A Common Stock    
Class of Stock [Line Items]    
Common stock number of votes per share   1
v3.24.1
Basis of Presentation and Significant Accounting Policies - Narrative (Details)
 12 Months Ended
Jan. 28, 2024
USD ($)
d
Jan. 28, 2024
USD ($)
segment
Jan. 29, 2023
USD ($)
Jan. 30, 2022
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Accounts receivable $ 154,043,000 $ 154,043,000 $ 126,969,000  
Accounts receivable, settlement period | d 5      
Impairment charges   0 0 $ 0
Fulfillment costs   1,300,000,000 1,200,000,000 1,200,000,000
Merchant processing fees   $ 234,000,000 $ 207,700,000 $ 183,800,000
Number of operating segments | segment   1    
Number of reportable segments | segment   1    
Revenue Benchmark | Supplier Concentration Risk | Three largest suppliers        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Concentration risk percentage   39.00% 38.00% 35.00%
Customer Receivables        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Accounts receivable $ 110,000,000 $ 110,000,000 $ 105,200,000  
Vendor Receivables        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Accounts receivable $ 44,000,000 $ 44,000,000 $ 21,800,000  
v3.24.1
Basis of Presentation and Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details)
Jan. 28, 2024
Furniture, fixtures and equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Property and equipment, useful life 5 years
Furniture, fixtures and equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Property and equipment, useful life 10 years
Computer equipment and software | Minimum  
Property, Plant and Equipment [Line Items]  
Property and equipment, useful life 3 years
Computer equipment and software | Maximum  
Property, Plant and Equipment [Line Items]  
Property and equipment, useful life 5 years
v3.24.1
Basis of Presentation and Significant Accounting Policies - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Accounting Policies [Abstract]    
Outbound fulfillment $ 491,251 $ 370,095
Advertising and marketing 106,339 99,593
Payroll liabilities 83,880 66,799
Accrued expenses and other 324,467 258,047
Total accrued expenses and other current liabilities $ 1,005,937 $ 794,534
v3.24.1
Basis of Presentation and Significant Accounting Policies - Schedule of Interest Income and Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Accounting Policies [Abstract]      
Interest income $ 62,083 $ 11,865 $ 523
Interest expense (3,582) (2,575) (2,164)
Interest income (expense), net $ 58,501 $ 9,290 $ (1,641)
v3.24.1
Basis of Presentation and Significant Accounting Policies - Schedule of Other Nonoperating Income (Expense) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Accounting Policies [Abstract]      
Change in fair value of equity warrants and investments $ 13,079 $ (13,340) $ 0
Foreign currency transaction gains 285 174 0
Change in fair value of equity investments (10) 0 0
Other income (expense), net $ 13,354 $ (13,166) $ 0
v3.24.1
Acquisitions - Schedule of Estimated Purchase Price, Net of Cash Acquired (Details) - USD ($)
$ in Thousands
 12 Months Ended
Nov. 07, 2022
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Business Acquisition [Line Items]        
Cash paid for acquisition of business, net of cash acquired   $ 367 $ 40,033 $ 0
Petabyte        
Business Acquisition [Line Items]        
Purchase price $ 43,281      
Less: cash acquired 2,881      
Cash paid for acquisition of business, net of cash acquired $ 40,400      
v3.24.1
Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Nov. 07, 2022
Assets acquired:      
Goodwill $ 39,442 $ 39,442  
Petabyte      
Assets acquired:      
Cash and cash equivalents     $ 2,881
Accounts receivable     104
Goodwill     39,442
Identified intangible assets     1,510
Other current and non-current assets     318
Liabilities assumed:      
Other current and long-term liabilities     (974)
Purchase price     $ 43,281
v3.24.1
Acquisitions - Narrative (Details) - USD ($)
Jan. 28, 2024
Jan. 29, 2023
Nov. 07, 2022
Business Acquisition [Line Items]      
Goodwill $ 39,442,000 $ 39,442,000  
Developed technology      
Business Acquisition [Line Items]      
Useful Life (years) 3 years    
Petabyte      
Business Acquisition [Line Items]      
Goodwill     $ 39,442,000
Expected tax deductible amount     0
Identified intangible assets     1,510,000
Petabyte | Developed technology      
Business Acquisition [Line Items]      
Identified intangible assets     $ 1,500,000
Useful Life (years)     3 years
v3.24.1
Financial Instruments - Narrative (Details) - USD ($)
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Investments, Debt and Equity Securities [Abstract]    
Accumulated gross unrealized gain (loss) $ 0  
Allowance for credit loss, period increase (decrease) 0  
Allowance for credit loss 0  
Deferred credits $ 1,900,000 $ 45,000,000
v3.24.1
Financial Instruments - Schedule of Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other non-current assets Other non-current assets
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents $ 602,232 $ 331,641
Equity investments 193 18
Marketable securities 531,785 346,944
Equity warrants 0 0
Total financial instruments 1,134,017 678,585
Level 1 | U.S. Treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
U.S. Treasury securities 531,592 346,926
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Equity investments 0 0
Marketable securities 0 0
Equity warrants 0 0
Total financial instruments 0 0
Level 2 | U.S. Treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
U.S. Treasury securities 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Equity investments 0 0
Marketable securities 0 0
Equity warrants 2,219 31,622
Total financial instruments 2,219 31,622
Level 3 | U.S. Treasury securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
U.S. Treasury securities 0 0
Cash | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 602,232 301,641
Cash | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Cash | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Money market funds | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 30,000
Money market funds | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 0 0
Money market funds | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents $ 0 $ 0
v3.24.1
Financial Instruments - Summary of Changes in Fair Value of Financial Instruments Using Unobservable Level 3 Inputs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 31,622 $ 0
Equity warrants acquired 0 44,962
Change in fair value of equity warrants $ (29,403) $ (13,340)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other income (expense), net Other income (expense), net
Ending balance $ 2,219 $ 31,622
v3.24.1
Financial Instruments - Summary of Quantitative Information About Level 3 Significant Unobservable Inputs Used in the Fair Value Measurement of the Equity Warrants (Details) - Level 3 - Fair Value, Recurring
$ in Thousands
Jan. 28, 2024
USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants $ 2,219
Minimum | Probability of vesting  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants, measurement input 0
Minimum | Equity volatility  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants, measurement input 0.35
Maximum | Probability of vesting  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants, measurement input 0.50
Maximum | Equity volatility  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants, measurement input 0.85
Weighted Average | Probability of vesting  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants, measurement input 0.18
Weighted Average | Equity volatility  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Equity warrants, measurement input 0.77
v3.24.1
Property and Equipment, net - Summary of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 827,286 $ 709,470
Less: accumulated depreciation and amortization 305,988 230,585
Property and equipment, net 521,298 478,885
Furniture, fixtures and equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 174,092 162,618
Computer equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 75,677 67,849
Internal-use software    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 183,380 139,082
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 312,123 246,386
Construction in progress    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 82,014 $ 93,535
v3.24.1
Property and Equipment, net - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Property, Plant and Equipment [Line Items]      
Depreciation expense $ 75.6 $ 57.5 $ 40.8
Internal-use software      
Property, Plant and Equipment [Line Items]      
Accumulated depreciation and amortization 87.5 57.4  
Amortization expense $ 30.2 $ 22.4 $ 14.2
v3.24.1
Identified Intangible Assets - Schedule of Intangible Assets (Details)
$ in Thousands
Jan. 28, 2024
USD ($)
Finite-Lived Intangible Assets [Line Items]  
Gross Carrying Amount $ 11,596
Accumulated Amortization (7,633)
Total intangible asset amortization $ 3,963
Weighted-Average Remaining Life (years) 1 year
Developed technology  
Finite-Lived Intangible Assets [Line Items]  
Gross Carrying Amount $ 11,596
Accumulated Amortization (7,633)
Total intangible asset amortization $ 3,963
Weighted-Average Remaining Life (years) 1 year
v3.24.1
Identified Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization of intangible assets $ 3.9 $ 3.5 $ 0.3
v3.24.1
Identified Intangible Assets - Schedule of Future Estimated Amortization of Intangible Assets (Details)
$ in Thousands
Jan. 28, 2024
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
2024 $ 3,585
2025 378
Total intangible asset amortization $ 3,963
v3.24.1
Commitments and Contingencies (Details) - patent
Apr. 11, 2022
Oct. 08, 2021
Feb. 15, 2021
Loss Contingencies [Line Items]      
Number of patents allegedly infringed   5  
Number of patents found not infringed 3 1  
Pending litigation      
Loss Contingencies [Line Items]      
Number of patents allegedly infringed     4
v3.24.1
Debt (Details) - Line of Credit - Revolving Credit Facility
 12 Months Ended
Jan. 28, 2024
USD ($)
Line of Credit Facility [Line Items]  
Line of credit facility principal $ 800,000,000
Line of credit facility additional aggregate principal increase limit $ 250,000,000
Minimum fixed charge coverage ratio 1.0
Excess availability as percent of maximum borrowing amount 10.00%
Excess availability maximum borrowing amount $ 72,000,000
Line of credit facility, current borrowing capacity 759,000,000
Outstanding borrowings $ 0
Minimum  
Line of Credit Facility [Line Items]  
Commitment fee percentage 0.25%
Base Rate | Minimum  
Line of Credit Facility [Line Items]  
Basis spread on variable rate 0.25%
Base Rate | Maximum  
Line of Credit Facility [Line Items]  
Basis spread on variable rate 0.75%
SOFR | Minimum  
Line of Credit Facility [Line Items]  
Basis spread on variable rate 1.25%
SOFR | Maximum  
Line of Credit Facility [Line Items]  
Basis spread on variable rate 1.75%
v3.24.1
Leases - Narrative (Details)
$ in Millions
 12 Months Ended
Jan. 28, 2024
USD ($)
renewalOption
Jan. 29, 2023
USD ($)
Jan. 30, 2022
USD ($)
Lessee, Lease, Description [Line Items]      
Assets acquired in exchange for operating lease liability $ 106.3 $ 92.1  
Lease expense 104.4 90.9 $ 79.7
Short-term and variable lease cost $ 24.8 $ 18.9 17.7
Weighted average remaining lease term 11 years 9 months 18 days 12 years  
Weighted average discount rate 8.40% 8.40%  
Operating lease payments $ 95.7 $ 76.8 $ 67.9
Real Estate      
Lessee, Lease, Description [Line Items]      
Number of renewal options | renewalOption 3    
Renewal term 5 years    
Minimum | Real Estate      
Lessee, Lease, Description [Line Items]      
Lease term 5 years    
Minimum | Equipment      
Lessee, Lease, Description [Line Items]      
Lease term 3 years    
Maximum | Real Estate      
Lessee, Lease, Description [Line Items]      
Lease term 15 years    
Maximum | Equipment      
Lessee, Lease, Description [Line Items]      
Lease term 5 years    
v3.24.1
Leases - Schedule of Lease Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Assets    
Operating $ 474,617 $ 423,518
Current    
Operating $ 29,003 $ 27,646
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses and other current liabilities Accrued expenses and other current liabilities
Non-current    
Operating $ 527,795 $ 471,821
Total operating lease liabilities $ 556,798 $ 499,467
v3.24.1
Leases - Schedule of Lease Maturity (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Operating Leases    
2024 $ 70,522  
2025 77,677  
2026 74,844  
2027 70,932  
2028 71,866  
Thereafter 534,553  
Total lease payments 900,394  
Less: interest 343,596  
Present value of lease liabilities $ 556,798 $ 499,467
v3.24.1
Stockholders’ Equity (Deficit) (Details)
 12 Months Ended
Jan. 09, 2024
shares
Apr. 12, 2021
shares
May 11, 2020
shares
May 08, 2020
shares
Jan. 28, 2024
vote
May 16, 2023
shares
Class A Common Stock            
Class of Stock [Line Items]            
Common stock number of votes per share | vote         1  
Conversion of stock, shares converted (in shares) 12,325,000          
Class A Common Stock | Buddy Chester Sub LLC            
Class of Stock [Line Items]            
Conversion of stock (in shares)       17,584,098    
Forward purchase agreement (in shares)     17,584,098      
Forward purchase agreement period     20 days      
Forward purchase agreement, total settlement (in shares)           17,584,098
Class A Common Stock | Argos Intermediate Holdco I Inc.            
Class of Stock [Line Items]            
Conversion of stock (in shares)   6,150,000        
Class B common stock            
Class of Stock [Line Items]            
Common stock number of votes per share | vote         10  
Common stock conversion ratio         1  
Conversion of stock, shares converted (in shares) (12,325,000)          
Percentage of outstanding stock         7.50%  
Class B common stock | Buddy Chester Sub LLC            
Class of Stock [Line Items]            
Conversion of stock (in shares)       (17,584,098)    
Class B common stock | Argos Intermediate Holdco I Inc.            
Class of Stock [Line Items]            
Conversion of stock (in shares)   (6,150,000)        
v3.24.1
Share-Based Compensation - Narrative (Details) - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Jul. 14, 2022
PRSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation cost $ 13.7      
Unrecognized compensation cost, recognition period 2 years      
Awards vested (in shares) 1,936      
PRSUs | Director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Awards vested (in shares) 100 200 200  
RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation cost $ 456.5      
Unrecognized compensation cost, recognition period 2 years 6 months      
Awards vested (in shares) 4,501      
2022 Plan | Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares allowed for issuance (in shares)       1,000
2022 Plan | Class A Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock reserved for future issuance (in shares) 26,000      
2022 Plan | Class A Common Stock | Common Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares allowed for issuance (in shares)       40,000
v3.24.1
Share-Based Compensation - Schedule of Service and Performance Based-Awards Activity (Details) - $ / shares
shares in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
PRSUs      
Number of PRSUs/ RSUs      
Beginning balance (in shares) 2,206    
Granted (in shares) 500    
Vested (in shares) (1,936)    
Forfeited (in shares) (217)    
Ending balance (in shares) 553 2,206  
Weighted Average Grant Date Fair Value      
Beginning balance (in dollars per share) $ 36.22    
Granted (in dollars per share) 26.91 $ 43.59 $ 80.85
Vested (in dollars per share) 35.89    
Forfeited (in dollars per share) 37.38    
Ending balance (in dollars per share) $ 28.49 $ 36.22  
RSUs      
Number of PRSUs/ RSUs      
Beginning balance (in shares) 10,813    
Granted (in shares) 14,228    
Vested (in shares) (4,501)    
Forfeited (in shares) (3,152)    
Ending balance (in shares) 17,388 10,813  
Weighted Average Grant Date Fair Value      
Beginning balance (in dollars per share) $ 45.56    
Granted (in dollars per share) 31.00 $ 41.54 $ 72.05
Vested (in dollars per share) 45.61    
Forfeited (in dollars per share) 39.94    
Ending balance (in dollars per share) $ 34.65 $ 45.56  
v3.24.1
Share-Based Compensation - Summary of Weighted Average Grant-Date Fair Value and Total Fair Value of Service and Performance Based-Awards Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
PRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant-date fair value (in dollars per share) $ 26.91 $ 43.59 $ 80.85
Total fair value of vested $ 74.8 $ 145.5 $ 318.2
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant-date fair value (in dollars per share) $ 31.00 $ 41.54 $ 72.05
Total fair value of vested $ 154.6 $ 47.6 $ 19.5
v3.24.1
Share-Based Compensation - Schedule of Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense $ 239,107 $ 158,122 $ 77,772
PRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense 1,896 12,710 27,423
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation expense $ 237,211 $ 145,412 $ 50,349
v3.24.1
Income Taxes - Narrative (Details) - USD ($)
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Tax Credit Carryforward [Line Items]      
Current income tax provision $ 8,700,000 $ 2,600,000 $ 0
Deferred income tax provision     0
Increase in valuation allowance 50,400,000    
Capitalized research expenditures 122,600,000 36,535,000  
Total loss carryforwards 130,382,000 177,627,000  
Tax credit carryforward 52,166,000    
Unrecognized tax benefits, interest on income taxes accrued 1,400,000    
Payments for tax sharing agreement with related parties 10,279,000 2,828,000 (43,714,000)
Payable for tax sharing agreement 5,300,000    
Income tax liabilities, indemnified 1,900,000,000    
Income taxes paid 1,799,758,000 $ 0 $ 0
Accrued Income Taxes 4,400,000    
Current Year Activity      
Tax Credit Carryforward [Line Items]      
Increase in valuation allowance 44,600,000    
Federal Tax Credits      
Tax Credit Carryforward [Line Items]      
Increase in valuation allowance 4,600,000    
Other Adjustments      
Tax Credit Carryforward [Line Items]      
Increase in valuation allowance 1,200,000    
Indemnification Agreement      
Tax Credit Carryforward [Line Items]      
Guarantor obligations 19,700,000    
Related Party      
Tax Credit Carryforward [Line Items]      
Income taxes paid 1,800,000,000    
Accrued Income Taxes 108,900,000    
Nonrelated Party      
Tax Credit Carryforward [Line Items]      
Income taxes paid 5,000,000    
Definitive expiration dates      
Tax Credit Carryforward [Line Items]      
Net operating loss carryforwards 210,600,000    
No expiration      
Tax Credit Carryforward [Line Items]      
Net operating loss carryforwards 277,500,000    
Federal      
Tax Credit Carryforward [Line Items]      
Net operating loss carryforwards 492,700,000    
State Tax Authority      
Tax Credit Carryforward [Line Items]      
Net operating loss carryforwards 488,100,000    
Foreign Tax Authority      
Tax Credit Carryforward [Line Items]      
Net operating loss carryforwards $ 20,400,000    
v3.24.1
Income Taxes - Effective Income Tax Rate Reconciliation (Details)
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Income Tax Disclosure [Abstract]      
Federal statutory rate 21.00% 21.00% 21.00%
Foreign earnings, net of taxes 2.80% 0.00% 0.00%
State income taxes, net of federal tax benefit (4.10%) 3.80% 10.90%
Change in tax rate 0.00% 2.50% (0.20%)
Share-based compensation and other nondeductible expenses 16.80% (24.40%) 73.00%
Tax credits (43.70%) (22.20%) 36.10%
Other 0.90% 3.30% (0.10%)
Change in valuation allowance 24.20% 21.00% (140.70%)
Effective rate 17.90% 5.00% 0.00%
v3.24.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Deferred tax assets:        
Operating lease liabilities $ 144,965 $ 129,786    
Inventories 13,313 10,897    
Share-based compensation 32,029 37,085    
Accrued expenses and reserves 16,495 13,468    
Net operating loss carryforwards 130,382 177,627    
Tax credit carryforwards 52,166 40,391    
Capitalized research expenditures 122,600 36,535    
Other 3,248 7,971    
Total deferred tax assets 515,198 453,760    
Less: valuation allowance 281,119 230,692 $ 217,032 $ 124,012
Deferred tax assets, net of valuation allowance 234,079 223,068    
Deferred tax liabilities:        
Operating lease right-of-use assets 123,563 109,827    
Depreciation 101,235 107,014    
Prepaids 7,289 6,227    
Other 1,992 0    
Total deferred tax liabilities 234,079 223,068    
Net deferred tax assets $ 0 $ 0    
v3.24.1
Income Taxes - Valuation Allowance Rollforward (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Valuation allowance, as of beginning of period $ 230,692 $ 217,032 $ 124,012
Valuation allowances established 50,434 14,970 93,199
Changes to existing valuation allowances (7) (1,310) (179)
Valuation allowance, as of end of period $ 281,119 $ 230,692 $ 217,032
v3.24.1
Income Taxes - Operating Loss Carryforwards (Details) - USD ($)
$ in Thousands
Jan. 28, 2024
Jan. 29, 2023
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, indefinite $ 114,724  
Total loss carryforwards 130,382 $ 177,627
2024    
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, subject to expiration 91  
2025    
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, subject to expiration 3  
2026    
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, subject to expiration 64  
2032    
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, subject to expiration 13  
2033    
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, subject to expiration 128  
Thereafter    
Operating Loss Carryforwards [Line Items]    
Total loss carryforwards, subject to expiration $ 15,359  
v3.24.1
Income Taxes - Tax Credit Carryforwards (Details)
$ in Thousands
Jan. 28, 2024
USD ($)
Tax Credit Carryforward [Line Items]  
Tax credit carryforward $ 52,166
Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 47,987
Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 3,655
Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 524
2025  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 128
2025 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2025 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2025 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 128
2026  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 273
2026 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 90
2026 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2026 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 183
2027  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 430
2027 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 217
2027 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2027 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 213
2038  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 17
2038 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 17
2038 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2038 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2040  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 417
2040 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2040 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 417
2040 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2041  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 8,917
2041 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 7,775
2041 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 1,142
2041 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2042  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 18,363
2042 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 16,267
2042 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 2,096
2042 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2043  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 23,621
2043 | Research and Development  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 23,621
2043 | Work Opportunity  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0
2043 | Quality Jobs Tax Credit  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward $ 0
v3.24.1
Income Taxes - Uncertain Tax Positions (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning balance $ 0 $ 0 $ 0
Additions due to parent reorganization transaction 18,298 0 0
Ending balance $ 18,298 $ 0 $ 0
v3.24.1
Earnings (Loss) per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Numerator      
Earnings (loss) attributable to common Class A and Class B stockholders $ 39,580 $ 49,899 $ (75,207)
Weighted-average common shares used in computing earnings (loss) per share:      
Basic (in shares) 429,457 422,331 417,218
Effect of dilutive share-based awards (in shares) 2,583 5,439 0
Diluted (in shares) 432,040 427,770 417,218
Anti-dilutive stock-based awards excluded from diluted common shares (in shares) 11,058 5,377 9,773
Earnings (loss) per share attributable to common Class A and Class B stockholders:      
Basic (in dollars per share) $ 0.09 $ 0.12 $ (0.18)
Diluted (in dollars per share) $ 0.09 $ 0.12 $ (0.18)
v3.24.1
Certain Relationships and Related Party Transactions (Details) - USD ($)
 12 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Related Party Transaction [Line Items]    
Noncash settlement with related parties $ 54,734,000  
Related Party    
Related Party Transaction [Line Items]    
Accounts payable, current 0 $ 60,300,000
BC Partners | Related Party    
Related Party Transaction [Line Items]    
Other receivables, current 48,300,000  
PetSmart | Related Party    
Related Party Transaction [Line Items]    
Other receivables, current $ 0